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Influenza viruses are respiratory pathogens that cause significant mortality worldwide. 
The subtype of influenza A virus currently affecting worldwide equine populations is 
H3N8, leading to epidemics and transboundary pandemics. The individual gene segments 
of an isolate named A/equine/Montana/9564-1/2015 were phylogenetically characterized. 
BLASTn search revealed that the polymerase basic protein 1 (PB1), polymerase acidic 
(PA), hemagglutinin (HA), nucleoprotein (NP), and matrix (M) segments of this H3N8 
isolate shared the highest percentage identity to A/equine/Tennessee/29A/2014 (H3N8) 
and the polymerase basic protein 2 (PB2), neuraminidase (NA), and non-structural 
protein (NS) segments to A/equine/Malaysia/M201/2015 (H3N8). Maximum likelihood 
phylogenetic trees constructed using H3N8 viral genomes of both equine and canine 
origin, established that A/equine/Montana/9564-1/2015 belonged to the Florida Clade 1 
viruses. 
A review of the current progress in influenza B virus (IBV) research includes the peer-
reviewed articles that have been published on five IBV proteins. Understanding the 
biology of the proteins encoded in the IBV genome, and their differences from IAV, is 
crucial in for vaccine research. The current understanding of the evolutionary dynamics 
and epidemiology of IBV is discussed which helps inform vaccine strategies and prevent 
 xi 
IBV infections. Although IBV is thought to primarily infect humans, there is evidence of 
sporadic infections occurring in other species. These studies of natural and experimental 
infections of IBV are discussed, followed by a summary of the current literature on the 
studies done in ferrets. 
Swine are susceptible to infection by IBV, indicating that IBV could be a swine pathogen 
and natural reservoir for IBV. The second study looked at the replication kinetics of 
Victoria and Yamagata lineages of IBV in swine primary nasal turbinate, trachea and 
lung epithelial cells. Productive replication of B/Brisbane/60/2008 (BR08); 
B/Florida/04/06 (FL06); B/Hong Kong/286/2017 (HK17) and B/Utah/09/2014 (UT14) 
was seen at 0.01 and 0.1 multiplicities of infection. Peak titers at 33˚C were greater than 
or equal to titers at 37˚C for most of the experiments. HK17 (Victoria lineage) grew to 
the highest titers in nasal turbinate and lung cells. Lineage-specific differences in 
replication could not be observed in this study. Molecular analysis of will shed more light 
on the role of swine in the pathogenesis of IBV.
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Chapter 1 Introduction and Objectives 
1.1 Classification of Influenza Viruses 
Influenza viruses belong to the family Orthomyxoviridae. Viruses that are a part of the 
Orthomyxoviridae family contain virions that are spherical or pleomorphic in shape. 
Influenza virions measure approximately 80-120 nm in diameter. They are enveloped 
viruses that contain a segmented negative sense RNA genome. Having diversified 
through evolution, influenza viruses are classified into types A, B and C. This 
classification is based on the antigenic differences in nucleocapsid (NP) and matrix (M1) 
proteins.  
Influenza A (IAV) and B (IBV) viruses are predominantly responsible for annual 
influenza in humans. Characterized by symptoms such as cough, fever, muscle and joint 
pain, sore throat and a runny nose, influenza is estimated to be responsible for 290,000 to 
650, 000 global deaths annually. This respiratory disease can spread rapidly, impacting 
children (less than 59 months old) and the elderly (older than 65 years of age) to a greater 
degree (W. Paul Glezen et al., 1980; Van Voris, Belshe, & Shaffer, 1982). Both IAV and 
IBV are included in the seasonal flu vaccine for humans.   
IAV is divided into subtypes based on the hemagglutinin (HA) and the neuraminidase 
(NA) proteins. 18 different HA subtypes and 11 different NA subtypes have been 
discovered. Isolated for the first time in 1940, Influenza B virus comprises of a single 
group of HA and NA antigens (Francis, 1940; Nerome et al., 1998). Unlike IAV which 
has been isolated from several wild and domestic animals such as swine, equine, seals, 
whales, mink and birds. IBV has been primarily associated with human infections 
(Cauldwell, Long, Moncorge, & Barclay, 2014). Despite humans being considered the 
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predominant host, there is evidence to show that other species such as pheasants, horses, 
dogs and seals can harbor IBV or possess antibodies specific to  IBV (Bodewes et al., 
2013; Chang CP, 1976; Kawano J, 1978). 
Unlike IAV and IBV which have eight genome segments, Influenza C virus (ICV) has 
seven genome segments. The Hemagglutinin Esterase Fusion (HEF) protein is the only 
glycoprotein present at the surface of the ICV virion. It combines the receptor binding 
activity (mediated by HA in IAV and IBV), receptor destroying activity (mediated by NA 
in IAV and IBV) and fusion activity in ICV (Georg Herrler & Klenk, 1991). There are 
reports of ICVs in pigs, feral dogs and dromedary camels, but ICV is primarily known to 
cause a mild respiratory disease in humans (Guo, Jin, Wang, Wang, & Zhu, 1983; 
Ohwada et al., 1987). 
Influenza D virus (IDV) was discovered in 2011 in a pig that showed influenza-like 
symptoms in Oklahoma. IDV shares approximately 50% homology to ICV, but 
differences in the receptor binding pocket of HE protein have modelled (Hause et al., 
2013). While IDV’s prevalence is highest in cattle with this agricultural animal as a 
primary reservoir, antibodies to IDV have been found in pigs, goats and sheep (Quast et 
al., 2015). Not much is known about the potential zoonotic transmission of IDV to 
humans, but increased transmission in animal reservoirs indicates that IDV may pose a 
public health concern (Hause et al., 2013). 
Influenza viruses have a wide host range, with some animal species being susceptible to 
infection by all four types of viruses. The segmented nature of influenza viruses enables 
reassortment when cells are infected simultaneously with different human and animal 
viruses. This is known as antigenic shift. Antigenic shift, which occurs in IAV can create 
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novel viruses to which humans are susceptible as they have no preexisting immunity. For 
example, the Hong Kong flu of 1968 which was caused by an antigenic shift of H2N2 
strain to H3N2 strain, caused the death of approximately one million people worldwide. 
Antigenic drift is the accumulation of mutations in genes of influenza viruses that code 
for antibody-binding sites. These mutations allow the virus to escape preexisting 
immunity and cause widespread mortality. The outbreaks due to antigenic drifts are 
usually less severe than the pandemics associated with antigenic shifts. These periodic 
changes in the antigenic properties of influenza viruses cause its epidemic nature. Thus, 
an understanding of the biology, epidemiology and transmission of influenza viruses in 
various species will aid in the development of antiviral therapies to fight infections. 
1.2 Structure and Genome Organization of Influenza Viruses 
The influenza virion contains helical ribonucleoprotein complexes (also called vRNPs). 
vRNPs are a central part of the viral life cycle. The virion has a viral envelope that 
contains a core. Three transmembrane proteins are a part of the viral envelope: HA 
(Hemagglutinin), NA (Neuraminidase) and M2 (Ion channel) are present on the outside; 
M1 (matrix protein) is present beneath the membrane. HA is the major protein forming 
the viral envelope. It contains binding sites for neutralizing antibodies as well as the sialic 
acid receptor. Cleavage of HA into HA1 and HA2 is essential for virus infection. NA, 
which forms tetrameric spikes, is responsible for removing the sialic acid receptor 
enabling release of infectious viral particles which causes spread of the infection. M2, the 
minor component of the viral envelope, functions as an ion channel. When influenza 
viruses are budding from infected cells, the outer lipid layer is taken from the host’s 
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plasma membrane. M2 protein is instrumental in the release and exit of the vRNPs from 
the M1 matrix (Nayak, Balogun, Yamada, Zhou, & Barman, 2009). 
The viral core has vRNPs that contain negative stranded vRNAs and nucleoprotein (NP). 
Nuclear export protein (NEP) is present in small amounts along with the three 
polymerase proteins named PB1, PB2 and PA. This forms the viral RNA polymerase 
complex (Wu & Voth, 2003). 
IAVs encode 10 polypeptides that are derived from 8 viral RNA segments (Figure 1.1). 
In IAV and IBV, segments 1, 3, 4 and 5 encode one protein per segment: PB2, PA, HA 
and NP proteins. Polymerase subunit 1 (PB1) is encoded on segment 2 in all influenza 
viruses. Some strains of IAV also have a PB1-F2 protein which contains 87 amino acids, 
in a +1 alternate reading frame. PB1- F2 has been implicated in killing host cells (W. 
Chen et al., 2001). While segment 6 encodes only the NA protein (Bouvier & Palese, 
2008) in IAV, in IBV it encodes the NB protein too in a -1 reading frame. NB protein 
corresponds to the M2 protein in IAV. IAV expresses the M2 ion channel from segment 
7, while IBV encodes its BM2 protein in a +2 alternate reading frame. NS1 interferon-
antagonist protein is expressed from segment 8 in both IAV and IBV. The NEP/NS2 
protein is expressed by mRNA splicing from this segment (Bouvier & Palese, 2008). 
ICV is similar in genome organization to IAV and IBV; it consists of only seven 
segments as HEF combines the functions of HA and NA. ICV uses Neu5,9Ac2 (N-acetyl-
9-O-acetylneuraminic acid), while IAV and IBV utilize Neu5Ac (N-acetylneuraminic 
acid). While human IAV preferentially binds to α2-6 linkage, avian IAV binds to α2-3 
linkage, and swine IAV can binds to both α2-6 and α2-3 linkages. ICV’s HEF recognizes 
Neu5,9Ac2 receptor regardless of its linkage to the next sugar. The HEF also has esterase 
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activity which cleaves acetyl from the C9 position of sialic acid-containing glycans (G. 
Herrler et al., 1985). 
 
Figure 1.1 Diagrammatic illustration of the genome organization of influenza A 
virion(Horimoto & Kawaoka, 2005) 
 
1.3 Replication of Influenza Viruses 
A diagrammatic illustration of the replication of influenza viruses is shown below (Figure 
1.2). The first step of virus replication is the virus entry. The HA protein undergoes 
cleavage into HA1 and HA2 by serine proteases. HA1 contains the receptor binding and 
antigenic sites, whereas HA2 mediates fusion of the viral envelope with the cell 
membrane. Viruses often undergo amino acid changes at antigenic sites, and these minor 
changes can accumulate in a process known as antigenic drift. After the virus is 
endocytosed, a low pH environment in the endosome facilitates a conformational change 
in the HA, and the fusion peptide is exposed. The viral envelope is then merged with the 
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endosomal membrane through the fusion peptide. After endocytosis, the M2 protein ion 
channel causes the flow of ions from the endosome to the interior of the virus. This 
causes a disruption in the protein-protein interactions within the cell allowing the release 
of the ribonucleoprotein structure from the membrane (M1) protein (Helenius, 1992). 
This allows RNPs to be released from the matrix of the virus into the cytoplasm of the 
cell.  
Viral proteins and RNPs are imported into the nucleus where the influenza viral RNA 
synthesis occurs. vRNA is the template to synthesize mRNA templates for viral protein 
synthesis. At the same time, vRNA is used as the template to make complementary RNA 
(cRNA) intermediates from which the RNA polymerase can transcribe more vRNA. The 
poly(A) tail is encoded in a negative sense vRNA, which is then transcribed into the 
positive sense mRNA. mRNA capping occurs through a process called “cap snatching”. 
PB1 and PB2 proteins are involved in taking 5’ capped primers from pre-mRNA 
transcripts of the host cell, to initiate viral mRNA synthesis. 
Viral mRNA is then exported and translated into viral proteins in a similar fashion to the 
host mRNA. vRNA is exported to the cytosol with the help of M1 and NEP/NS2 
proteins. Within the RNA complex, vRNA and NP interact with M1. NEP also interacts 
with M1 to mediate the export of the M1-RNP complex via nucleoporins in the 
cytoplasm. HA, NA and M2 envelope proteins are synthesized from the mRNA of viral 
origin on the ribosomes. They are moved into the endoplasmic reticulum, where folding 
occurs. Following folding, the mRNA is trafficked into the Golgi apparatus for post-
translational modifications.  
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In the next step, the viral RNA is packaged and assembled. There is evidence that 
packaging signals exist on vRNA segments which helps the full genome incorporate into 
the viral particles efficiently. After assembly, influenza virus budding occurs. Influenza 
HA protein is a driving force for virus to pinch-off from the cell surface of infected cells 
with the help of influenza M2 protein. Virus particles are released through the sialidase 
activity of NA protein. Through NA’s activity of breaking down mucins in the respiratory 
tract, it aids in virus infectivity. 
 
Figure 1.2 Replication of influenza viruses  
(Arias et al., 2009) 
 
1.4 Epidemiology and evolution of EIV and IBV 
Influenza A viruses infect animals and humans, whereas influenza B viruses mainly 
infect humans. Influenza A virus is considered to be the ancestor of all other influenza 
viruses. H7N7 and H3N8 are the subtypes that are related to equine influenza. H3N8 is 
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the only subtype that currently circulates in equines. Isolated for the first time in 1963, 
A/eq/Miami/63 is considered the prototype EIV isolate (Waddell, Teigland, & Sigel, 
1963).  
The oldest H3N8 EIV isolates, dated from 1963 to 1988, were grouped under the pre-
divergence lineage. Differences in the sequence analysis of the HA gene led to the 
classification of EIV into the Eurasian and American lineages. The American lineage 
evolved into the Argentinian, Kentucky and Florida sub lineages (Lai et al., 2001). The 
Florida sub lineages can be further classified into Clade 1 and Clade 2 viruses. Clade 1 
viruses include representative strains such as A/eq/South Africa/04/2003-like and 
A/eq/Ohio/2003-like viruses, and has caused outbreaks in Mongolia, India and China. 
Clade 2 viruses are representative of strains like A/eq/Richmond/1/2007-like viruses. 
Interestingly, some isolates from Europe have changes in their amino acid sequences 
which makes them similar to Clade 2 lineages viruses (Bryant et al., 2009). 
Studies on the phylogeny of EIV from different parts of the world have demonstrated the 
evolution of EIV. Surveillance studies in North America detected the presence of EIV in 
Canada and West Indies. A 56.6% morbidity rate of EIV amongst equine respiratory 
outbreaks was seen in Ontario, Canada during five different outbreaks (Diaz-Mendez et 
al., 2010). EIV antibodies have also been reported from horses and donkeys in the 
Leeward Islands of West Indies (Bolfa et al., 2017). A high prevalence of antibodies 
against EIV has also been reported in Brazil, with movement and aggregation of animals 
possibly causing high rates of transmission (Favaro et al., 2018).  
The genetic evolution EIV in France showed that American and Eurasian lineages 
prevailed till 2003, but after 2005 the Florida sub lineage Clade 2 was dominant 
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(Legrand, Pitel, Cullinane, Fortier, & Pronost, 2015). EIV isolates were detected in 
Ireland, Sweden and the UK as well (Back et al., 2016; Gildea, Quinlivan, Arkins, & 
Cullinane, 2012). Several of these studies highlight the possibility of reassortment as a 
mechanism for EIV evolution. 
Asia had EIV infections in several countries such as China, Mongolia, India and Japan 
(Qi et al., 2010). Amino acid changes in the antigenic sites were seen in Asian strains of 
Florida sub lineage clade 2. Differences between the isolates and the vaccine strain were 
due to amino acid substitutions in A, B and C antigenic regions (Qi et al., 2010). Thus, 
the emergence of newer strains due to mutations is an issue worldwide. The high number 
of circulating strains and lack of cross-protection highlights the importance of regular 
surveillance and evolutionary profiling of this respiratory disease.  
Unlike IAV which is divided into several subtypes based on the antigenicities of 
hemagglutinin (HA) and the neuraminidase (NA) proteins, IBV does not have any 
subtypes. In the 1980s, IBV diverged into two genetically and antigenically distinct 
lineages named Victoria and Yamagata after B/Yamagata/16/88 and B/Victoria/2/87, 
which were the original isolates (Rota et al., 1990). The Victoria lineage viruses belong 
to the B/Brisbane/60/2008 genetic clade (Group 1), whereas the Yamagata lineage 
viruses are classified into two clades. Group 2 in the Yamagata lineage is represented by 
B/Brisbane/3/2007, and Group 3 is represented by B/Bangladesh/3333/2007. In seasons 
where IBV was predominant or co-circulating alongside influenza A virus (IAV), 
Victoria lineage predominated 64% of seasons, whereas Yamagata lineage predominated 
36% of seasons (Caini et al., 2015) 
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Victoria-like viruses were prevalent worldwide in the 1980s, but the Yamagata emerged 
worldwide in the 1990s. In some parts of Asia, Victoria-like viruses circulated in the late 
1990s, but this lineage re-emerged globally in 2001. Phylogenetic trees constructed from 
the HA genes showed that the Victoria lineage comprised of a single tree-trunk that had 
several side branches which circulated for short periods of time indicating that it 
undergoes greater positive selection, whereas Yamagata lineage has multiple clades 
circulating at the same time (Vijaykrishna et al., 2015). Additionally, Yamagata viruses 
bind predominantly to α-2,6-linked sialic acid host receptors whereas Victoria viruses 
bind to both α-2,3 and α-2,6 binding capacities.  
Molecular analysis of viral genes provides an insight into the epidemic potential of 
different strains. Phylogenetic analysis, in particular, enables the identification of 
circulating strains belonging to different lineages (Lindstrom et al., 1999; Rota et al., 
1990). performing a molecular analysis of viral genes provides an insight into the 
epidemic potential of different strains by allowing the identification of amino acid 
residues that contribute to antigenic drift. Phylogenetic analysis also enables the 
identification of circulating strains belonging to different lineages (Lindstrom et al., 
1999; Rota et al., 1990). 
Epidemiological studies from several European countries like Belgium, Spain, Finland 
and Israel highlight the reassortment of circulating strains. Phylogenetic analysis of 
circulating strains reveal an evolutionary pattern of IBV that has alternatingly dominant 
lineages and their co-circulation during a particular season.  
 
1.5 Objectives 
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The aim of the study in chapter 2 was to characterize an equine H3N8 virus isolate. This 
isolate was obtained from a 3-year-old unvaccinated horse having respiratory disease, 
from Montana, USA, in 2015. Phylogenetically distinct clades/lineages of EIV have been 
co-circulating globally, posing a challenge in the selection of vaccine strains. 
Understanding the evolutionary profile of EIV helps estimate the phylogenetic diversity 
and distribution of equine influenza viruses. Phylogenetic characterization of all the eight 
gene segments of this isolate was done using currently available sequences of both canine 
and equine H3N8 subtypes in the influenza virus resource database. 
Current progress in IBV research is discussed in Chapter 3. Findings on IBV proteins 
such as the polymerase proteins, nucleoprotein, non-structural protein 1, matrix protein 
and hemagglutinin proteins are discussed in brief. The epidemiology of Victoria and 
Yamagata lineages of IBV are discussed, and the evolutionary dynamics of IBV. Non-
human IBV infections are discussed: both experimental and natural.  
The ability of IBV to infect swine primary respiratory epithelial cells derived from the 
nasal turbinate, trachea and lung cells of a day-old gnotobiotic piglet was investigated in 
chapter 4. The effect of different multiplicities of infection and temperature on IBV 
replication was also looked at in this study. The replication of B/Brisbane/60/2008 
(BR08) and B/Hong Kong/286/2017 (HK17) belonging to the Victoria lineage, and 
B/Florida/04/06 (FL06) and B/Utah/09/2014 (UT14) belonging to the Yamagata lineage 
was studied at 33˚C and 37˚C. The three primary cells, and MDCK cells which were used 
as a positive control, were infected with the four strains of IBV at 0.01 and 0.1 
multiplicities of infection. This study aids in a greater understanding of the pathogenesis 
of IBV in swine. 
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Chapter 2  Phylogenetic Analysis of a Sporadic Isolate of Equine Influenza A H3N8 
from an Unvaccinated Horse in 2015 
2.1 Abstract 
Equine influenza, caused by the H3N8 subtype, is a highly contagious respiratory disease 
affecting equid populations worldwide and has led to serious epidemics and 
transboundary pandemics. This study describes the phylogenetic characterization of a 
recently isolated H3N8 virus from a nasal swab obtained from a sporadic case of natural 
infection in an unvaccinated horse from Montana, USA.  BLASTn search revealed that 
the polymerase basic protein 1 (PB1), polymerase acidic (PA), hemagglutinin (HA), 
nucleoprotein (NP), and matrix (M) segments of this H3N8 isolate shared the highest 
percentage identity to A/equine/Tennessee/29A/2014 (H3N8) and the polymerase basic 
protein 2 (PB2), neuraminidase (NA), and non-structural protein (NS) segments to 
A/equine/Malaysia/M201/2015 (H3N8). Phylogenetic characterization of individual gene 
segments, using currently available H3N8 viral genomes, of both equine and canine 
origin, further established that A/equine/Montana/9564-1/2015 belonged to the Florida 
Clade 1 viruses. This study provided us insights about the evolutionary relationship and 
in vitro cross-species infectivity of A/equine /Montana/9564-1/2015 (H3N8) virus. 
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2.1 Introduction 
Equine influenza epizootics, which affect horses, zebra, mules, and donkeys all over the 
world, are characterized by an acute dry cough, high body temperature, mucopurulent 
nasal discharge, lethargy and anorexia (Cardwell, Newton, Wood, Geraghty, & Ellis, 
2000; Lai et al., 2001; Mumford et al., 1998; Timoney, 1996). Vaccination failure, the 
mobility of unvaccinated horses and insufficient quarantine measures are major 
predisposing factors for equine influenza occurrence in places where EIV is endemic 
(Cullinane & Newton, 2013). Equine influenza viruses are type A viruses and the major 
subtypes affecting horses include H7N7 and H3N8 which were previously designated as 
equine 1 and equine 2 viruses. However, currently, H3N8 (Kitchen, Kehler, & 
Henthorne, 1963) is the only subtype affecting worldwide equine populations. 
A1/equine/Prague/56 was the first H7N7 prototype isolated from Prague, Czech 
Republic, which affected horses in Sweden and Eastern Europe around 1955–1956 
(Scholtens, Steele, Dowdle, Yarbrough, & Robinson, 1964; Sovinova, Tumova, Pouska, 
& Nemec, 1958; Webster, 1993). Equine H3N8 prototype, A2-equine/Miami/63 was 
originally isolated from Miami, Florida in 1963, as an upper respiratory disease 
manifestation in imported animals from Argentina (Kitchen et al., 1963; Waddell et al., 
1963; Wilson, Bryans, & Doll, 1965). Since 1979, only H3N8 variants have been found 
in circulation, even though both H7N7 and H3N8 co-circulated in the equine populations 
in earlier times (Cullinane & Newton, 2013; Daly et al., 1996; Webster, 1993). It is 
believed that homo/intra and hetero/inter-subtype reassortments have played a crucial 
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role in the evolution dynamics of equine influenza virus (EIV), where intra-subtype 
reassortments enhanced virulence in EIV H3N8, and inter-subtype reassortments led to 
the extinction of EIV H7N7 (Murcia, Wood, & Holmes, 2011). Compared to H7N7, 
H3N8 affects horses of all ages, irrespective of vaccination coverage. Previous studies on 
the phylogeny of EIV from different parts of the world have clearly demonstrated the 
evolution of equine influenza viruses, particularly the H3N8 subtype, which is the 
prominent subtype in circulation (Alves Beuttemmuller et al., 2016; Bountouri, 
Fragkiadaki, Ntafis, Kanellos, & Xylouri, 2011; Fougerolle et al., 2017; Olguin 
Perglione, Golemba, Torres, & Barrandeguy, 2016; Perglione et al., 2016; Rash et al., 
2017). EIV H3N8 has been causing major transcontinental pandemics across the world 
and has crossed over species to successfully establish in the canine host since 2004 
(Crispe, Finlaison, Hurt, & Kirkland, 2011). 
The equine H3N8 subtype diverged genetically into American and Eurasian lineages 
around the 1980s, however American lineages have been circulating in Europe and vice-
versa (Bryant et al., 2009; Daly et al., 1996). No cases of Eurasian lineages have been 
reported since 1994 (Murcia et al., 2011). Around 1990, the American lineage diverged 
antigenically and genetically into Kentucky, South America and Florida sub-lineages 
with the Florida sub-lineage circulating predominantly (Lai et al., 2001). Around the 
early 2000s, the Florida sub-lineage diverged into two clades: Clade 1 (FC1) and Clade 2 
(FC2) (Bryant et al., 2009; Xie, Anderson, Daramragchaa, Chuluunbaatar, & Gray, 2016; 
Yamanaka et al., 2016). Even though the clade separation was not so pronounced for the 
H3N8 isolates in 2002–2003, the divergence became indisputable for strains isolated after 
2005 (Paillot, 2014). Since 2007, all Asian and European isolates have been found to 
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belong to FC2, whereas North American isolates belong to FC1, but the reverse can also 
occur, owing to the increased international mobility of the animals for races and 
exhibition. Such activities can lead to loose transmission bottle-neck and mixed 
infections, which may contribute to vaccination failures (Hughes et al., 2012; Murcia et 
al., 2011). 
Cross-species transmission of EIV in canines, characterized by the complete genome 
transfer of equine H3N8, occurred initially in the United States, followed by the UK and 
Australia in the early 2000s (Gonzalez et al., 2014; Kirkland, Finlaison, Crispe, & Hurt, 
2010). Canine influenza, caused by H3N8, has been associated with fever, cough, 
suppurative pneumonia and per-acute death (Crawford et al., 2005; Daly et al., 2008; 
Kirkland et al., 2010; Murcia & Wood, 2011). Both cats and calves have been 
experimentally infected with EIVs and the infected animals showed clinical symptoms, 
virus shedding and demonstrated contact transmission (Lin et al., 2010; Su et al., 2014; 
Tu et al., 2009). Interestingly, two H3N8 strains of equine origin, with close relation to 
the European H3N8 EIVs, were isolated from pigs in China during 2004–2006 (Tu et al., 
2009). Experimental infection of humans with EIV H3N8 was demonstrated more than 
50 years ago by the National Institute of Health and it was found that humans are 
susceptible to H3N8 with clinical manifestations (Kasel, Alford, Knight, Waddell, & 
Sigel, 1965; Minuse, McQueen, Davenport, & Francis, 1965; Morens & Taubenberger, 
2010). Further, serological evidence of EIV H3N8 has been reported in humans with 
occupational exposure indicating its zoonotic potential (Larson et al., 2015). These 
evidence of cross-species transmission and broad host spectrum raise the possibility of 
zoonosis and thus could have a serious implication on public health. 
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Previous outbreaks in vaccinated and unvaccinated horses in Europe in 1979 and 1989 
showed that EIV can undergo a rapid rate of antigenic drift and cause vaccination failures 
(Van Oirschot, Bruin, de Boer-Luytze, & Smolders, 1991; van Oirschot, Masurel, 
Huffels, & Anker, 1981). The Office International des Epizooties (OIE) vaccine 
recommendations remain unchanged since 2010, and mandates to include both clades—
FC1 represented by A/eq/South Africa/04/2003-like or A/eq/Ohio/2003-like viruses and 
FC2 represented by A/eq/Richmond/1/2007-like viruses. The OIE also recommends 
periodical update of the vaccine strains, based on the epidemiological survey results 
(Paillot et al., 2016). While, vaccination is the only solution to effectively control and 
prevent EIV outbreaks, the continuous antigenic drift between the strains poses a serious 
threat for necessary protection, especially for horses involved in cross country events 
(Elton & Cullinane, 2013). Continued surveillance and reporting of EIV from different 
countries is of utmost importance, to ensure the effective coverage of circulating strains 
by the current vaccine strains and thereby boosts herd immunity. 
The aim of this study was to phylogenetically characterize all eight segments of an equine 
H3N8 virus isolate, obtained from a 3-year-old unvaccinated gelding showing respiratory 
disease, from Montana, USA, in 2015. Phylogenetically distinct clades/lineages of EIV 
have been co-circulating globally, undergoing gene reassortments, thereby posing a 
serious challenge in the selection of vaccine strains. Hence, understanding the 
evolutionary profile of EIV is imperative to estimate the phylogenetic diversity and 
distribution of equine influenza viruses. Our phylogenetic analysis inferred that the 
polymerase basic protein 1 (PB1), polymerase acidic (PA), and nucleoprotein (NP) 
segments of A/equine/Montana/9564-1/2015 clustered with 
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A/equine/Tennessee/29A/2014 and hemagglutinin (HA), polymerase basic protein 2 
(PB2), neuraminidase (NA), matrix (M), and non-structural (NS) segments clustered with 
A/equine/Malaysia/M201/2015 and A/equine/Tennessee/29A/2014, both belong to Clade 
1 (FC1) viruses of Florida sub-lineage (Bao et al., 2008). 
 
2.2 Materials and Methods  
A BLASTn search analysis, optimized for highly similar sequences (megablast), was 
conducted for all the eight gene segments of A/equine/Montana/9564-1/2015 (H3N8) (Y. 
Chen, Ye, Zhang, & Xu, 2015). 
Both canine and equine nucleotide sequences of H3N8 subtype were acquired from the 
influenza virus resource (https://www.ncbi.nlm.nih.gov/genomes/FLU/Database/nph-
select.cgi?go=database, accessed 5 January 2018) and phylogenetic analyses were 
performed using MEGA 7.0. Nucleotide sequences were aligned using Multiple 
Sequence Comparison by Log-Expectation (MUSCLE) and the evolutionary history of 
each segment was inferred by constructing maximum likelihood trees, using the best 
nucleotide substitution models, suggested by the ‘test for best DNA/ protein fitness’ in 
MEGA 7.0 (Bao et al., 2008; Edgar, 2004). The best nucleotide substitution models 
inferred for maximum likelihood trees for the gene segments were general time-
reversible with gamma distributed with invariant sites (GTR+G+I) for PB2, PB1, NP; 
Tamurai–Nei with gamma distributed with invariant sites (TN93+G+I) for PA, HA; 
general time-reversible with gamma distributed (GTR+G) for NA; Hasegawa-Kishino-
Yano with gamma distributed with invariant sites (HKY+G+I) for M; Hasegawa–
Kishino–Yano with gamma distributed (HKY+G) for NS (Hasegawa, Kishino, & Yano, 
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1985; Rodriguez, Oliver, Marin, & Medina, 1990; Tamura & Nei, 1993). All nucleotide 
positions containing gaps and missing data were partially deleted and very strong branch 
filters were applied to run the analysis. For each taxon, the bootstrap value was 
determined from 1000 replicates to verify the tree topology. 
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2.3 Results: 
 
Figure 2.1 Phylogenetic analysis of the HA sequence. The evolutionary history of 
hemagglutinin (HA) nucleotide sequence of A/equine/Montana/9564-1/2015 was inferred 
using the maximum likelihood method by MEGA 7.0, with a bootstrapping of 1000 
replicates. The analysis involved 161 sequences of both canine and equine origin, and 
canine H3N8 strains were shown as a collapsed branch. Different phylogenetic groups of 
equine influenza virus (EIV) were color-coded and marked. Orange filled square = pre-
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divergence; Green filled circle = Eurasian; pink filled diamond = American lineage 
(Kentucky + Argentina); Blue filled triangle = Florida sub-lineage Clade 2; Red Open 
square = Florida sub-lineage Clade 1. Bootstrap values are shown at each node and 
A/equine/Montana/9564-1/2015 is highlighted in red. 
 
Figure 2.2 Phylogenetic analysis of the NA sequence. The evolutionary history of 
neuraminidase (NA) nucleotide sequences of A/equine/Montana/9564-1/2015 was 
inferred using the maximum likelihood method by MEGA 7.0, with a bootstrapping of 
1000 replicates. The analysis involved 161 sequences of both canine and equine origin, 
and canine H3N8 strains were shown as a collapsed branch. Different phylogenetic 
groups of EIV were color-coded and marked. Orange filled square = pre-divergence; 
Green filled circle = Eurasian; pink filled diamond = American lineage (Kentucky + 
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Argentina); Blue filled triangle = Florida sub-lineage Clade 2; Red Open square = Florida 
sub-lineage Clade 1. Bootstrap values are shown at each node and 
A/equine/Montana/9564-1/2015 is highlighted in red. 
 
 
 
Figure 2.3 Phylogenetic trees of PB2, PB1, NP, NA, M and NS sequences.Phylogenetical 
analyses of nucleotide sequences of PB2, PB1, PA, NP, M, and NS segments of 
A/equine/Montana/9564-1/2015 were inferred using the maximum likelihood method by 
MEGA 7.0 [48], with a bootstrapping of 1000 replicates. The analysis involved EIV 
sequences of both canine and equine origin, and canine H3N8 strains were shown as a 
collapsed branch. Subtrees, involving Florida sub-lineage Clade 1 (Red open square) and 
Florida Clade 2 (Blue filled triangle) viruses, are shown. Bootstrap values are shown at 
each node and A/equine/Montana/9564-1/2015 is highlighted in red. 
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2.3.1 BLAST Analysis 
The sequences of the eight segments—polymerase basic protein 2 (PB2), polymerase 
basic protein 1 (PB1), polymerase acidic (PA), hemagglutinin (HA), nucleoprotein (NP), 
neuraminidase (NA), matrix (M1 and CM2), and non-structural proteins (NS1, NS2)—
were obtained in full length, and sizes were 2341, 2274, 2151, 1762, 1572, 1410, 982, 
and 838 nucleotides (nt) respectively. Only the NA segment was nearly complete, with 
20 and 30 nt missing at the 5′ and 3′ terminal regions, respectively. The sequences were 
submitted to GenBank and accession numbers were assigned: MG198996 (PB2), 
MG198997 (PB1), MG198998 (PA), MG198999 (HA), MG199000 (NP), MG199001 
(NA), MG199003 (M), and MG199003 (NS). The BLASTn search analysis, optimized 
for highly similar sequences (megablast) for all the eight segments of 
A/equine/Montana/9564-1/2015, demonstrated the highest percentage identity to the 
H3N8 strains of equine origin and not to any of the H3N8 strains of canine origin, 
indicating the absence of any species cross over and intra-subtype genetic exchange. 
A/equine/Montana/9564-1/2015 demonstrated equally high percentage identity to six 
H3N8 strains isolated from Tennessee in 2014 (A/equine/Tennessee/4A/2014, 
A/equine/Tennessee/27A/2014, A/equine/Tennessee/28A/2014, 
A/equine/Tennessee/28B/2014, A/equine/Tennessee/29A/2014, 
A/equine/Tennessee/30A/2014) and A/equine/Malaysia/M201/2015. Considering the 
sequence similarity between these highly homologous strains, we used 
A/equine/Tennessee/29A/2014 as a representative strain for BLASTn results and 
phylogenetic analysis. A/equine/Montana/9564-1/2015 showed a percent identity score of 
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99.78 (PB1), 99.81 (PA), 99.54 (HA), 99.87 (NP), and 99.8 (M) to 
A/equine/Tennessee/29A/2014, while the PB2, NA and NS segments demonstrated 
percent identities of 99.83, 99.93 and 100 respectively, to 
A/equine/Malaysia/M201/2015. The HA segment of A/equine/Montana/9564-1/2015 also 
showed percent identity scores of 99.23% and 99.18% with two strains from Malaysia, 
A/equine/Malaysia/M201-2/2015 and A/equine/Malaysia/M201-1/2015. Overall, 
A/equine/Montana/9564-1/2015 shared the highest percent identity with two equine 
H3N8 viruses of Florida Clade 1 sub lineage, A/equine/Tennessee/29A/2014 and 
A/equine/Malaysia/M201/2015. 
 
2.3.2. Phylogenetic Analysis 
To estimate the evolutionary history of A/equine/Montana/9564-1/2015, we performed 
phylogenetic analyses of all the eight gene segments, with the currently available 
sequences of both canine and equine H3N8 subtypes in the influenza virus resource 
database (Bao et al., 2008; Chang et al., 2007). The EIV sequences we analyzed, included 
the sequences from pre-divergence, Eurasian and American lineages (Kentucky and 
South American sub-lineages) and Clades 1 and 2 of the Florida sub-lineage. The total 
number of canine and equine sequences of H3N8 subtype, used to construct the 
phylogenetic trees for each segment 
were PB2 (124), PB1 (130), PA (120), HA (161), NP (122), NA (161), M (121) 
and NS (121). For the phylogenetic analyses, we used a fixed number of nucleotides for 
each gene 
 24 
segment: PB2 (2280), PB1 (2274), PA (2151), HA (1695), NP (1497), NA (1410), M (98
2), and NS (838). 
The evolutionary history of the eight viral gene segments obtained by the phylogenetic 
analyses was in complete agreement with the percent identity score obtained by 
BLASTn, clustering with equine influenza A H3N8 viruses and not with canine H3N8 
viruses. The evolutionary history of HA and NA segments of A/equine/Montana/9564-
1/2015, was shown as complete trees, in which the different phylogenetic groups of EIV 
were color-coded and grouped to describe the pre-divergence, Eurasian and American 
lineages (strains from Kentucky and Argentina/South American sub-lineages), the Florida 
sub-lineage and Clade 1 and Clade 2 viruses (Figure 2.1 and Figure 2.2). The 
phylogenetic tree of the NA segment of our isolate, clustered with 
A/equine/Malaysia/M201/2015 and A/equine/Tennessee/29A/2014 (Figure 2.2). A 
similar cluster can be seen in the phylogenetic tree of HA. The HA segment of 
A/equine/Malaysia/M201/2015 was not available in the database; however, 
the HA segment of A/equine/Montana/9564-1/2015 clustered with another strain from 
Malaysia, i.e., A/equine/Malaysia/M201-1/2015 along with 
A/equine/Tennessee/29A/2014 (Figure 2.1). The oldest H3N8 EIV isolates, dated from 
1963 to 1988, were grouped under the pre-divergence lineage and the isolates from 
Europe and Asia from 1989 to 1994 were grouped under the Eurasian lineage (Fougerolle 
et al., 2017). Isolates, dated from 1990 to 2001, that belonged to the Kentucky and 
Argentina/South American sub-lineages, were grouped under American lineage, along 
with Florida sub-lineage Clade 1 and Clade 2 viruses, isolated from 2005 to present 
(Bryant et al., 2009; Lai, Rogers, Glaser, Tudor, & Chambers, 2004; Paillot, 2014).  
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2.4 Discussion 
EIV H3N8 epidemics have been reported worldwide, on a large scale, since the first 
reported case of H3N8 occurred in Florida in 1963. Just like any other influenza epidemic 
in the past, EIV epidemics occur in vaccinated and immunologically naïve populations, in 
particular, H3N8 EIV epidemics can happen in horses of all ages, regardless of 
vaccination status (Alves Beuttemmuller et al., 2016; Guthrie, 2006; Paillot & El-Hage, 
2016; Pusterla et al., 2015). Vaccination breakdowns have been associated with EIV 
outbreaks in the past, as documented in thoroughbred yearlings in Kentucky, and several 
other parts of the world, including France and Ireland and horses imported into South 
Arabia and Japan (Pusterla et al., 2015).  
According to the OIE Expert Surveillance Panel on Equine Influenza Vaccine 
Composition, the year 2015 witnessed an increased activity in H3N8 EIV cases, reported 
from 46 premises over 23 states in the USA (Office International des Epizooties (OIE) 
Conclusions and Recommendations, 2017). In 2016, 30 confirmed EIV cases were 
reported from 16 states (Office International des Epizooties (OIE) Conclusions and 
Recommendations, 2017). Unfortunately, there is no vaccination data available on these 
outbreaks from the USA. In 2015–2016, EIV outbreaks were reported in other parts of 
the world, such as Ireland, Sweden, and the UK. The outbreaks reported in the UK 
occurred in unvaccinated animals. As per the report, no cases have been reported from 
Asia and South America during this period (Office International des Epizooties (OIE) 
Conclusions and Recommendations, 2017). The OIE report also concluded that EIV 
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H3N8 viruses isolated from the USA in 2016 were homologous to the isolates from 2015 
and belonged to the Florida sub-lineage Clade 1 (FC1). On the other hand, viruses 
detected from the UK in 2015–2016 were Florida sub-lineage Clade 2 (FC2) viruses. The 
data we obtained from phylogenetic analysis were in complete agreement with this 
observation. 
The BLASTn analysis of all viral genome segments, except PB2, NA, and NS, showed 
the highest percentage identity to six H3N8 EIV strains isolated from Tennessee in 2014. 
Considering the percentage identity between these six highly homologous strains, we 
used A/equine/Tennessee/29A/2014 as a representative strain for our phylogenetic 
analysis. It was very difficult to conclude that this sporadic infection occurred from the 
contaminated premises, as there were no other horses on the premises reported to have 
EIV infection, according to available information to us. We also checked the influenza 
virus database (https://www.ncbi.nlm.nih.gov/genomes/FLU/Database/nph-
select.cgi?go=database, accessed 5 January 2018) to gather information on the EIV 
isolates reported from North America from 2000 to 2017. It is noteworthy that, only 1/69 
isolates (A/equine/Montana/9233/2007(H3N8)) have been reported from Montana during 
the past 17 years. According to the report from the OIE Expert Surveillance Panel, EIV 
cases occurred in the USA in 2015–2016 (Office International des Epizooties (OIE) 
Conclusions and Recommendations, 2017). However, we could not find any 
documentation of new recent EIV isolates from North America during 2015–2017, which 
indicates either the new isolates are homologous to the old known strains or lack of 
reporting of the new isolates. The phylogenetic analysis, using the maximum likelihood 
algorithm, used all the available full-length sequences of H3N8 currently available in the 
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database, of both equine and canine origins. The phylogenetic reconstruction of the 
individual genes was in complete agreement with the BLAST results and 
A/equine/Montana/9564-1/2015 clustered with FC1 viruses, originated in the USA. The 
fact that PB2, NA, M, NS and HA segments clustered with 
A/equine/Malaysia/M201/2015 (H3N8) is interesting, because Malaysia has been EIV 
free since 1977 and this outbreak in 2015, which started as a sporadic case occurred in a 
time frame, concurrent with the import of four racehorses 
(http://www.oie.int/wahis_2/public/wahid.php/Reviewreport/Review?reportid=19160, 
accessed 5 January 2018). Historically, EIV originating from Asia and Europe, usually 
clusters with Florida Clade 2 viruses. On the contrary, A/equine/Malaysia/M201/2015 
clustered with Florida Clade 1 viruses, together with A/equine/Tennessee/29A/2014. It is 
difficult to trace the time and means of introduction of A/equine/Malaysia/M201/2015 in 
the USA. It is worth noting that the sequences currently available in the database for 
A/equine/Malaysia/M201/2015 are only for four segments, i.e., PB2, NA, M, and NS. 
Only HA sequence is available for A/equine/Malaysia/M201-1/2015. The BLASTn 
percent identity score of M segment showed 99.8% and 99.59% to 
A/equine/Tennessee/29A/2014 and A/equine/Malaysia/M201/2015, respectively. Had 
there been all eight segments available, A/equine /Montana/9564-1/2015 might have 
shown a higher sequence identity to A/equine/Malaysia/M201/2015 than Tennessee 2014 
strains. Overall, A/equine/Montana/9564-1/2015 viral segments clustered with Florida 
Clade 1 viruses, A/equine/Tennessee/29A/2014 and A/equine/Malaysia/M201/2015 and 
hence, belong to the Florida Clade 1 group of equine influenza viruses. 
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Overall, this study provided us insights about the evolutionary relationship of A/equine 
/Montana/9564-1/2015 (H3N8) virus. A comprehensive genome-scale analysis of new 
isolates is essential to understand the molecular evolution and phylodynamics of EIV, 
which in turn would help in the strategic selection of vaccine strains, effective 
surveillance, and control. Antigenic and genetic variations caused by evolutionary 
processes play a critical role in determining the dynamics of host range and tropism of 
influenza viruses. In vivo studies are needed to evaluate the cross-species transmissibility 
of EIV H3N8 and its ability to cause infections and respiratory diseases in other 
mammalian hosts, including humans. 
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Chapter 3  Current Progress in Influenza B Virus Research 
3.1 Introduction 
Influenza viruses belonging to the Orthomyxoviridae family, are important viral 
pathogens that can cause significant respiratory disease. Influenza A virus (IAV) and 
influenza B virus (IBV) are the two types of influenza viruses that co-circulate in 
humans.  
IBV has a genome chain length of 14,639 nucleotides. Understanding the biology of the 
11 encoded proteins of IBV encoded in this genome, and their differences from IAV, is 
crucial in for vaccine research. This review discusses the peer-reviewed articles that have 
been published on five IBV proteins in brief. Two lineages of IBV co-circulate in most 
regions around the world, prompting the usage of the quadrivalent vaccine containing 
two IBV strains every flu season to prevent vaccine mismatch. This review summarizes 
the current understanding of the evolutionary dynamics and epidemiology of IBV which 
help inform vaccine strategies and prevent IBV infections.  
Isolated for the first time in 1940, IBV is thought to be primarily a human pathogen. 
However, there is evidence that other non-human species are susceptible to IBV 
infections as well. This review discusses these studies of natural and experimental 
infections of IBV, followed by a summary of the current literature available on the 
studies done in ferrets. 
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3.2 IBV Proteins 
The eight segments of the IBV genome encode 11 proteins [4]. There are three RNA-
dependent RNA polymerase subunits (PB1, PB2 and PA), hemagglutinin (HA), 
nucleoprotein (NP), neuraminidase (NA), matrix protein (M1) and two nonstructural 
proteins (NS1 and NS2). IBV also has two unique proteins NB and BM2, which are 
encoded by segment 6 and segment 7, respectively (Hatta, Goto, & Kawaoka, 2004). 
This review discusses the polymerase proteins, NP, NS-1, M1 and HA proteins in brief. 
3.2.1 Polymerase Proteins of Influenza B virus (PB1, PB2 and PA) 
PB1, PB2 and PA proteins are trimeric complexes that, along with the nucleoprotein 
(NP), are essential for expression of the viral genome (Jambrina, Barcena, Uez, & 
Portela, 1997). These viral RNA-dependent RNA polymerases play a role in the 
transcription and replication of the IBV genome. Each polymerase protein has a nuclear 
localization function. While PA and PB1 associate with the cytoplasm and the nucleus, 
the PB2 protein locates exclusively to the nucleus (Deng et al., 2011).  
Understanding the assembly and nuclear transport for the polymerase complex would 
provide new avenues to develop therapeutics to fight IBV infections. An RNA synthesis 
assay was developed that could be adapted to screen for polymerase inhibitors (Reich, 
Guilligay, & Cusack, 2017). Small molecule compounds have also been identified that 
inhibit the growth of IBV by inhibiting the binary complexes formed between the 
polymerase units (Muratore et al., 2012). 
During the initiation of viral mRNA synthesis, the RNA polymerase protein produces 
capped RNA fragments by cleaving the host mRNAs (Wakai, Iwama, Mizumoto, & 
Nagata, 2011). Studies done between the polymerase proteins of influenza A virus and 
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IBV showed that there is an incompatibility between the subunits of both types of viruses 
for RNA transcription and replication (Crescenzo-Chaigne, Naffakh, & van der Werf, 
1999; Iwatsuki-Horimoto et al., 2008; Wunderlich et al., 2010). Analysis of the crystal 
structure of IBV’s PB2cap shows affinity for m7GDP and GDP, unlike IAV’s PB2cap 
which prefers m7GDP (Liu et al., 2015). In the IBV PB2cap.m7 GTP complex, the 
methyl group is missing, and the guanine and ribose moieties are inverted around the 
long axis of the base. These properties allow IBV to bind to a wider range of cap binding 
structures compared to IAV (L. L. Xie et al., 2016).  
Phylogenetic analysis of 20 IBV sequences revealed lineage-specific amino acid 
substitutions in the three polymerase proteins. The three segments have maintained 
separate lineages, which helps preserve the viral fitness (Dudas, Bedford, Lycett, & 
Rambaut, 2014). Additionally, a functional association seems to exist between PA, NP 
and M proteins as well as the PB1 and PB2 proteins (Hiromoto et al., 2000). Differences 
in the topology of the PA gene phylogenetic tree showed that the polymerase genes don’t 
co-evolve as a unit; there is significant reassortment between the viruses (Hiromoto et al., 
2000).  
3.2.2 Nucleoprotein (NP) 
NP, which is a critical component of the ribonucleoprotein complex of IBV, plays a role 
in the transcription and replication of the viral genome. This basic protein consists of 560 
amino acids and has a molecular mass of 62kDa. Containing a head, body and tail loop, 
the RNA-binding groove is found at the end of the tetrameric structure (Ng et al., 2012).   
Several structural differences exist between the nucleoprotein of IBV and IAV. The N-
terminus of IBV’s NP, which is longer than IAV by 50 amino acids is not critical for the 
 32 
viral RNA’s transcription or replication. It was shown that the nuclear protein of IBV 
could not be replaced by the NP of IAV. N-terminal deletions of amino acid residues in 
the positions 51 and 69 in B/Ann Arbor/1/66 virus NP did not have any impact on the 
nuclear accumulation of the protein. (Stevens & Barclay, 1998).  The nucleoprotein of 
IBV inhibits the replication and polymerase activity of IAV in a dose dependent manner.  
A study conducted later looked at the role of the NP protein during viral infection instead 
of protein expression like the previous studies. Contradicting results were seen, showing 
that virus attenuation followed mutations in the viral NP protein. It was also seen that 
mutation in the N-terminal region had an effect of the transcription and replication of the 
virus during infection (Sherry, Smith, Davidson, & Jackson, 2014). 
3.2.3 Non-Structural Protein 1 (NS1) 
IBV induces the ISG15 protein during infection, which blocks the conjugation of ISG15 
protein. The RNA-binding domain of the NS1 protein is responsible for this inhibition 
(Yuan & Krug, 2001). When an embryonated chicken egg was infected with a mutant 
virus that lacked the NS1 gene, viral growth was not supported. The mutant NS1-IBV 
induced IFN-ß in human lung epithelial cells in higher levels than the wild-type virus, 
indicating that NS1 protein has a function as a viral IFN antagonist (Dauber, Heins, & 
Wolff, 2004). IBV’s NS1 protein can complement IAV and result in infection when 
IAV’s NS1 is deleted. In the absence of other viral proteins, it was seen that IRF-3 
nuclear translocation and IFN-ß promoter was still activated by the N terminal and C 
terminal independently (Donelan et al., 2004). dsRNA-binding regions exist on IBV NS1 
protein that form the binding epitope, which consists of conserved tracks of basic and 
hydrophilic residues (Yin et al., 2007). An important study showed that the limited host 
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range of IBV is caused in part due to the species-specific binding of the NS1 protein. 
ISG15 protein, which is ubiquitin-like, is induced by the alpha/beta-interferon, and plays 
an important role in antiviral activity against influenza. NS1 of IBV binds to human and 
non-primate ISG15, but not mouse or canine ISG15. This shows the possibility of IBV 
infecting non-human primates, but not mice or canines without adaptive mutations 
(Sridharan, Zhao, & Krug, 2010). Further studies in other animals to show the role of 
NS1 in ISGlylation would provide further insight in the biology of IBV and help in the 
development of more accurate models (Versteeg et al., 2010).  
The crystal structure of the N-terminal region of the NS1 protein in conjugation with 
human ISG15 showed that this region interacts with a pair of ISG15 molecules (Guan et 
al., 2011). A high affinity binding site is formed around the ISG15 protein’s N-terminal 
domain and NS1 protein as a result of the low affinity binding between them (Li et al., 
2011). A novel RNA-binding site was discovered in the C-terminal domain of IBV that is 
not present in IAV (Ma et al., 2016). 22 human proteins were such as DHX9, ILF3 etc., 
were found to interact with two RNA-binding domains of IBV NS1 protein. SNRNP200 
was identified as a positive regulator caused by host IFN responses. ILF3 exhibited dual 
roles in the induction of IFN and the replication of IBV (Patzina, Botting, Garcia-Sastre, 
Randall, & Hale, 2017).  
3.2.4 Influenza B Matrix Protein 2 (BM2) 
Encoded by the 7th RNA genome segment, the BM2 protein is translated via a 
termination-dependent initiation from a bi-cistronic mRNA in an open reading frame that 
is +2 nucleotides from the matrix (M1 protein). BM2 protein is made up of a 7-residue 
ectodomain, a 19-residue transmembrane domain, and an 82-residue cytoplasmic tail. 
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Key residues in the transmembrane domain such as His19, Trp23 and His27 play a role in 
BM2 activity and opening the channel (Otomo, Toyama, Miura, & Takeuchi, 2009; 
Rouse, Carpenter, Stansfeld, & Sansom, 2009). The BM2 initiation codon overlaps with 
the M1 termination codon, and this unique stop-start mechanism can be utilized to 
express multiple proteins from one mRNA (Hatta, Kohlmeier, Hatta, Ozawa, & 
Kawaoka, 2009). BM2 forms a tetrameric structure where the channel pore is surrounded 
by four protein bundles (Balannik, Lamb, & Pinto, 2008).  
Several studies showed that BM2 is an integral membrane protein that closely associates 
with cellular proteins (Paterson, Takeda, Ohigashi, Pinto, & Lamb, 2003; Watanabe, 
Imai, Ohara, & Odagiri, 2003). Similar to the M2 protein in IAV, the BM2 protein can 
transform the pH of the trans-golgi network (Betakova & Hay, 2009). Its function as a 
proton-selective ion channel was thought to help in uncoating the virus in virus-infected 
cells. When transmembrane (TM) domain residues Ser9, Ser12, Phe13, Ser16, His19, and 
Trp23 in the BM2 ion channel were mutated to cysteine, the greatest disruption in ion 
channel function was observed (Taylor, Udo, Lamb, & Pinto, 2005). NMR spectroscopy 
studies provided detailed structural information about the BM2 TM peptide which 
contains a histidine in the tetrameric transmembrane (Williams, Shcherbakov, Wang, & 
Hong, 2017; Williams, Tietze, Lee, Wang, & Hong, 2016).  
To investigate BM2’s function, BM2 knockout viruses were generated using reverse 
genetics. Initial studies showed that BM2 is essential for IBV replication and infectivity, 
playing a role in the assembly of the viral ribonucleoprotein complex into the virion 
(Hatta et al., 2004; Imai, Watanabe, Ninomiya, Obuchi, & Odagiri, 2004; Jackson, 
Zurcher, & Barclay, 2004). The cytoplasmic domain of BM2 has been found to play a 
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role in aiding the association of the M1 protein with lipid membranes and virion 
morphology (Imai, Kawasaki, & Odagiri, 2008). 
The growth of IBV and BM2 activity are not hindered by the antiviral drug amantadine. 
The ion channel’s pore is lined with polar serine residues and not hydrophobic amino 
acids, and this confers drug resistance to the BM2 protein. The use of more polar 
compounds is essential in inhibiting BM2 and disrupting viral infectivity (Pinto & Lamb, 
2006; Taylor et al., 2005). The BM2 proton channel is a good antiviral target: a 
monoclonal antibody targeting the ectodomain of BM2 proton channel inhibited viral 
replication (Y. J. Wang et al., 2010). DNA enzymes containing the 10-23 catalytic motif 
against the RNA of IBV BM2 can effectively inhibit viral RNA replication. This makes 
the DNA enzymes a good candidate to develop a therapeutic agent against IBV (Kumar 
et al., 2013). It has also been shown that BM2 can replace IAV’s M2 protein to support 
viral replication (Wanitchang, Wongthida, & Jongkaewwattana, 2016).  
3.2.5 Hemagglutinin (HA) 
The HA protein is a surface protein that binds to the sialic acid of the host cell in the 
early stages of influenza infection. This receptor binding specificity of HA plays an 
important role in determining the host range of the influenza virus.  
It was shown that in cells of CV-1 origin carrying the SV40 genetic material, HA and 
Neuraminidase (NA) proteins accumulate in the trans-golgi network, enabling HA to get 
desialidated before the proteins migrate to the cell surface. In Madin-Darby Canine 
Kidney cells, de-sialidation occurs on the cell surface (Luo, Nobusawa, & Nakajima, 
2002). The NA protein removes sialic acid from the HA protein as well as cellular 
glycolipids or glycoprotein, thereby preventing the aggregation of virus particles and 
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permitting the release of virus from host cell receptors (Palese et al., 1974; Shibata et al., 
1993).  
HA is a homotrimer, with each monomer HA0 composed of a globular head and stem. 
The native HA0 is cleave by proteases HA1 contains the residues that form the receptor 
binding pocket in the head. They facilitate interaction with the host cell. The stem 
contains the fusion peptide that is necessary for cytosolic release. It is encoded by both 
HA1 and HA2. HA2 is also conserved across IAV and IBV. 
Homology modelling of the HA1 structure of Influenza B virus showed that two amino 
acid types could be present at the position 269:  Residue 269 is Pro in the Yamagata sub 
lineage, unchanged since B/Lee/ 40, but Ser in all viruses of the Victoria sub-lineage. 
This provides the signature for the two lineages into which the influenza B virus HA 
bifurcated in 1978 (Hay et al., 2001). The cytoplasmic tail of Influenza B virus regulates 
fusion depending upon the amino acid sequence. The hydrophobicity of a single amino 
acid was important in syncytium formation. It was seen that Leucine was not essential for 
HA-mediated fusion (Ujike, Nakajima, & Nobusawa, 2006). 
The HA0 sequence has a dual functional constraint, i.e., to remain a suitable substrate for 
host-encoded proteases and to maintain a functional fusion domain. Since HA0 cleavage 
occurs extracellularly in all human influenza viruses, it is an appropriate target for 
antibody response. Because of its functional constraints, the epitope is extremely well 
conserved, providing the vaccine with broad specificity against all circulating influenza B 
viruses. Three amino acids were found to be conserved, particularly site 197 in the 
B/Victoria viruses that were analyzed (Pechirra et al., 2005). 
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It was seen that amino acid variation, while highest at the surface positions, had no 
relationship to the degree of variability in the HA loop. Compensatory changes are made 
to neutralize charges in a loop (Tung, Goodman, Lu, & Macken, 2004). Acylation was 
not significant in membrane fusion by, but the pore formation and pore dilation were 
appreciably affected by the amino acid sequence of the cytoplasmic tail and the existence 
of a single acylation site in cytoplasmic tail residue 578.  
 
3.3 Epidemiology of the Victoria and Yamagata lineages 
In a comprehensive epidemiological study conducted across 20 countries worldwide, 
influenza B (IBV) data was analyzed for the seasons between 2000-2013. 20% of all 
influenza cases reported in these countries were due to IBV, highlighting the importance 
of IBV when studying the epidemiology of influenza infections (Caini et al., 2015). 
Another study done for the Asia-Pacific region identified IBV to be the cause of 0% to 
92% of laboratory-confirmed cases of influenza in a given season/year (Jennings et al., 
2018). Despite clear indications that IBV has a serious impact on human health, there is a 
scarcity in literature about the epidemiology of this virus. Greater number of local studies 
are required to better understand IBV’s burden (Tafalla, Buijssen, Geets, & Noordegraaf-
Schouten, 2016).  
Since 1983, two distinct evolutionary pathways have existed, changing the landscape of 
IBV’s epidemiology (Rota et al., 1990). The B/Yamagata/16/88 and B/Victoria/2/87 
lineages are genetically and antigenically distinct (Biere, Bauer, & Schweiger, 2010). 
While Victoria-like viruses were prevalent worldwide in the 1980s, the Yamagata lineage 
took over in the 1990s. In some parts of Asia, Victoria-like viruses circulated in the late 
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1990s, but this lineage re-emerged globally in 2001. Co-circulation of both lineages was 
seen during certain years. In seasons where IBV was predominant or co-circulating 
alongside influenza A virus (IAV), Victoria lineage predominated 64% of seasons, 
whereas Yamagata lineage predominated 36% of seasons (Caini et al., 2015).  
Epidemiological dynamics of the Victoria and Yamagata lineages vary significantly. 
Phylogenetic trees constructed from the HA genes showed that the Victoria lineage 
comprised of a single tree-trunk that had several side branches which circulated for short 
periods of time. The Victoria lineage undergoes greater positive selection pressure, which 
makes the virus more likely to undergo antigenic drift. The Yamagata lineage is more 
conserved than the Victoria lineage, with multiple clades circulating for longer periods of 
time (Vijaykrishna et al., 2015).  
Studies have shown the Yamagata viruses bind predominantly to α-2,6-linked sialic acid 
host receptors whereas Victoria viruses bind to both α-2,3 and α-2,6 binding capacities. 
This correlates to the different age distributions of humans that are susceptible to 
infections by the two lineages, since children have a greater number of α-2,3 receptors 
and a lower level of α-2,6 receptors compared to adults.  
Thus, differences in the hemagglutinin binding preferences influence the phylodynamic 
patterns of both lineages, with the Victoria lineage being more susceptible to seasonal 
bottlenecks and antigenic selection. The Yamagata lineage is more likely to infect older 
people and has lower transmission rates. 
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3.4 Evolutionary dynamics of IBV 
Understanding the evolutionary dynamics of influenza is essential for the prevention and 
management of viral infection. Historically, emerging epidemic strains were classified by 
antigenic analysis. Hemagglutination Inhibition assay may not always provide 
information regarding evolutionary relationships as viruses from different lineages have 
different amino acid substitutions at key positions which is not always reflected by 
changes in the HI assay in terms of antigenic properties. Thus, performing a molecular 
analysis of viral genes provides an insight into the epidemic potential of different strains 
by allowing the identification of amino acid residues that contribute to antigenic drift. 
Phylogenetic analysis also enables the identification of circulating strains belonging to 
different lineages (Lindstrom et al., 1999; Rota et al., 1990). 
Molecular analysis of circulating IBV strains in the 1998-2001 influenza seasons in 
Quebec, Canada revealed distinct evolutionary patterns in the HA1, NS1 and NA protein 
sequences. Isolates from 1998-1999 period were not closely related to the vaccine strain 
(B/Harbin/7/94) of that year when a comparison of HA1 and NS1 sequences was done, 
but similarities existed in the NA sequences (Abed, Coulthart, Li, & Boivin, 2003).  
Analysis of isolates from 2001-2002 winter season in European countries such as 
Belgium, Spain, Finland and Israel revealed the categorization of IBVs into the 
B/Yamagata/16/88 or B/Victoria/2/87 lineages. The appearance of B/Victoria/2/87 
lineage viruses marks the spread of this lineage from Asia to Europe, with Israel being a 
possible geographic route. Progression of the flu season led to a dominance of B/Hong 
Kong/1351/02-like viruses in these countries aided by the advantages of reassortment 
(Chi, Bolar, Zhao, Rappaport, & Cheng, 2003).  The Yamagata lineage, on the other 
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hand, dominated Beijing, China in 2013-2014. While HA segments were derived from 
the Yamagata lineage, NA segments were derived from the Victoria lineage, showing the 
reassortment had an important role in the evolution of IBVs in this region as well (Fang 
et al., 2015). 
Phylogenetic analysis of IBV isolates from the years 2004-2012 in Taiwan provided 
insight into the evolutionary processes that cause a persistent virus to become 
predominant. HA sequences from 2007 to 2012 were used to track epidemiological 
changes in TW08-I which caused an epidemic in the 2011-2012 influenza season in 
Taiwan. Drift mutations were seen in several gene segments of Yamagata lineage viruses 
derived from TW08-I (Yang et al., 2012).  
Surveillance of IBV strains from 1996-2012 in Sao Paulo, Brazil was conducted.  Some 
years had either Victoria or Yamagata lineages viruses dominating, whereas other years 
like 2005, 2006 and 2008 saw a cocirculation of both lineages. This alternating pattern 
could be the cause of decrease in vaccine match that is observed, highlighting the need 
for quadrivalent vaccines containing strains from both lineages of IBV (Paiva et al., 
2013). Similar studies in Riyadh, Saudi Arabia during 2010-2011and Italy during 2010-
2015 point to co-circulation of the Victoria and Yamagata lineages. Variations in the 
amino acid sequences of HA and NA proteins of the circulating strains point to the need 
for increased surveillance to discover newly emerging strains (Ali, Amer, & Almajhdi, 
2014; Tramuto et al., 2016). Analysis of IBV strains between 1995-2008 in Malaysia 
pointed at a dominant lineage (Victoria or Yamagata) that alternated every 1-3 years. 
Specific amino acid substitutions in the HA segment and frequent introductions of both 
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lineages into Malaysia was thought to contribute to this evolutionary pattern (Sam et al., 
2015).  
Thus, distinct evolutionary patterns of IBV can be observed based on epidemiological 
studies conducted in Europe, Asia and South America.  The alternating dominance of 
both lineages and their co-circulation in an influenza season are common. Reassortment 
between circulating strains and drift mutations that affect the antigenicity of the viruses 
contribute to IBV evolution. Gaining a better understanding of IBV’s epidemiology can 
inform antiviral therapies and vaccine formulation to combat its infection.  
 
3.5 Natural Occurrence of Influenza B in Non-Human Species 
The first evidence of influenza B infection in pigs was observed in 1966 in Budapest, 
Hungary, where influenza B outbreaks in humans resulted in cough, serous nasal 
discharge and conjunctivitis in pigs. Analysis of eight infected farms was done by 
collecting 924 swine serum samples, and in four farms 8 to 24 percent of pigs had a HI 
antibody titer to IBV. However, direct reproduction of IBV in the respiratory tract was 
not observed (Takatsy & Farkas, 1969). Earlier this year, a study done in Taiwan showed 
the first evidence of natural IBV-infected swine in a clinical setting. Genetic 
characterization of the IBVs showed that they belonged to the B/Brisbane/60/2008 
genetic clade of Victoria. This was considered to be a sporadic case of IBV transmission 
from humans to pigs (Tsai & Tsai, 2019). There is also a report of IBV isolation from 
horses as mentioned by Kawano and group, but the article could not be accessed 
(Kawano J, 1978).  
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In 1971, IBV that resembled B/Victoria/98926/70 was isolated from a 2-month-old 
Dachshund in Taipei city. This was the first Influenza B virus isolate of canine origin 
obtained under natural conditions (Chang CP, 1976). Failure to re-isolate the virus or 
obtain a HI antibody titer one month later caused Chang CP et. al. to conclude that the 
virus failed to produce an antigenic response in the dog or that the dog might have 
contracted the virus from infected humans whom it shared a close contact with. Zoo and 
migratory birds in Hungary had an outbreak due to IBV infection. 4.1% of the animals 
tested had IBV antibodies, demonstrating the susceptibility of avian species to IBV 
(Romvary, Meszaros, & Barb, 1980).  
In the spring of 1999, 12 juvenile harbor seals (Phoca vitulina) that were stranded near 
the Dutch coast had respiratory problems. Growth in cell culture, electron microscope 
analysis and subsequent reverse transcriptase polymerase chain reaction confirmed the 
presence of IBV in these animals. Lower viral shedding and delayed IgG antibody 
response to HA and NA was observed. Phylogenetic analysis indicated a lack of genetic 
or antigenic drift of IBV in seals. This influenza B/Seal/Netherlands/1/99 virus was 
similar to strains that circulated in humans 4 or 5 years earlier (Fouchier, Bestebroer, 
Martina, Rimmelzwaan, & Osterhaus, 2001). This was the first evidence of IBV in seal 
populations, highlighting the possibility of seals being an animal reservoir that new IBVs 
can emerge from. Virus attachment was seen in the epithelial cells of the respiratory tract 
in seals, consistent with the previously mentioned study (Ramis, van Riel, van de Bildt, 
Osterhaus, & Kuiken, 2012).  
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3.6 Seroprevalence studies of IBV in Non-Human Species 
A study done in Japan in 1978 indicated that antibodies to Influenza B virus were present 
in 16 out of 504 horse sera and 1 out of 1030 swine sera (0.1%) that were tested. All the 
positive horses were born in 1976, which was the same year that a human outbreak of 
influenza B occurred. It was therefore suggested that these horses might be infected from 
man (Kawano J, 1978). In 2000, sera collected from 971 seals showed a prevalence of 
antibodies to Influenza B virus in 2% of the animals after 1995, but none before 1995. 
Wild pigs in Croatia were positive for hemaggutination-inhibition (HAI) antibodies 
against virus B/Beijing/184/93-like strain in 68 (67.32%) samples in a study conducted in 
the same year (Zupancic et al., 2000). Two years later, antibodies to Influenza B virus 
were found in serum samples collected from Caspian seals (Phoca Caspica). 14% of 
samples collected in 1997 and 10% of samples collected in 2000 were detected positive 
by ELISA (Ohishi et al., 2002). HAI titers to Influenza B virus was observed in cervid 
sera from Croatia. 31% of free-ranging and 54% of captive cervids that were studied had 
an antibody titer of >1:20 (Zupancic et al., 2002).  
Indirect evidence of Influenza B virus was also seen in South American fur seal 
(Arctocephalus australis) samples in Uruguay. This was the first evidence of IBV in this 
species (Blanc et al., 2009). In 2013, serum samples from harbor seals and gray seals 
living in Dutch coastal waters during 2002-2012 were analyzed. It was shown that 9 out 
of 21 samples collected in 2010 were positive, whereas only 1 out of 150 samples was 
positive in 2011. This study showed that seals were infected by a virus closely 
resembling B/Yamanashi/166/98, but antigenically different from B/Seal/ 
Netherlands/1/1999 (Bodewes et al., 2013).  
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3.7 Cell cultures utilized in the study of IBV 
Cell cultures are widely used for the production of influenza vaccines. Vaccine 
manufacturers use several continuous cell lines, amongst which Madin-Darby Canine 
Kidney (MDCK) cells are the most extensively used. Guinea pig serum was seen to 
inhibit the infectivity of IBV grown in chick embryo or MDCK cells (Yamamoto et al., 
1987). It was seen that viral envelope of IBV was disrupted, degrading the M1 protein 
and genomic RNA (Goshima et al., 1988). However, cell cultures derived from the 
organs of animals, known as primary cell cultures, offer several advantages. Although 
they have limited growth in vitro, they represent an environment closest to the in vivo 
condition. Use of primary cell cultures can help inform in vivo studies or eliminate the 
need for them depending on the study’s requirements. Primary cells from several non-
human species have been used to study IBVs.  
Primary ferret kidney cell cultures exhibited cytopathic effects when infected with four 
different strains of IBV in 1970 (Johnson & Schieble, 1970). The metabolic activity of 
seven different IBV strains was measured using hamster tracheal organ cultures 
(Gurevitz, Schulze, Swierkosz, Arens, & Schwarz, 1987). Ferret airway cells inoculated 
with IBV and IAV from different lineages also supported efficient replication with little 
variation between the strains. Lower titers were observed in the cells infected with IBV 
compared to IAV (Elderfield et al., 2015).  
Mink lung epithelial cells contain alpha-2,6 and alph-2,3 receptors, which are essential 
for the entry of influenza virus, at levels that are similar to MDCK cells. A mink lung 
epithelial cell line was created which supported IBV infection (Schultz-Cherry, Dybdahl-
 45 
Sissoko, McGregor, & Hinshaw, 1998). Chick embryo brain cultures supported the 
replication of influenza B viruses when enriched with neurons or astroglial cells (Parker, 
Spence, & OCallaghan, 1997). 
 
3.8 Use of Ferrets and Other Non-Human Species to Study IBV 
The ferret is a widely used animal to study the replication, transmission and pathogenesis 
of Influenza A viruses. Several clinical symptoms and laboratory signs are similar when 
ferrets and humans are infected with human or avian IAV. Unlike mice which require 
attenuation, ferrets are naturally infected with IBV. The sialic acid receptors in the 
respiratory tract of both species are comparable, making ferrets a useful animal to model 
human or avian influenza infection. Additionally, transmission and seroconversion of 
IAV has been detected in ferrets. 
In contrast, experimental infections of IBV in ferrets have been few. Ferrets were used to 
study the metabolic changes occurring during convalescence from IBV infection. One 
study indicated an alteration in the lipid metabolism 24 hours after dissemination of the 
virus during convalescence (Kang, Galloway, Bean, Cook, & Olson, 1991). Another 
study looked at the hepatic lipid disturbances and ferrets as a possible model to study the 
steatosis of Reye’s syndrome (Kang et al., 1991).  
Ferrets have also been used to study the effect of antiviral agents of IBV infection. 
Single-dose treatments of 2'-FluorodGuo and 2'-FluorodDAP in ferrets infected with 
B/Singapore/222/79 inhibited viral replication in the upper respiratory tract, although the 
response was reduced in comparison to ferrets infected with IAV (Jakeman, Tisdale, 
Russell, Leone, & Sweet, 1994). The ability of peramivir, an influenza neuraminidase 
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(NA) inhibitor, to block IBV infection was tested in ferrets. A single intravenous 
infection of peramivir was seen to lower viral titers and symptoms in ferrets following 
infection with IBV  (Kitano et al., 2011). The fitness of neuraminidase resistant IBVs was 
studied in ferrets to obtain a better understanding of the public health threat that they 
could pose (Pascua et al., 2016). In order predict the amino acid substitutions that may 
arise when IBV strains are under prolonged exposure to zanamivir, a neuraminidase 
inhibitor, IBV was passaged in vitro under zanamivir pressure. A NA mutation E117D 
was identified that conferred resistance, but caused decreased viral replication in ferrets 
(Oh et al., 2018). 
Studies comparing IAV and IBV infections in ferrets showed that lower pathogenesis was 
seen in IBV-infected ferrets compared to IAV. Milder clinical symptoms were thought to 
be the result of lower viral replication in the lungs. This reduced viral replication was also 
implicated in the lower induction of inflammatory cytokines TNF-a and IFN-a (Y. H. 
Kim, Kim, Cho, & Seo, 2009). Another study used an outbred ferret model to model the 
genetic diversity in humans. Infection of these outbred ferrets with multiple IAV and IBV 
strains showed that the mildest clinical symptoms were observed in IBV strains. The 
disease severity was correlated to the antibody response in the upper respiratory tract of 
ferrets. (Huang et al., 2011).  
The expression of immune molecules such as cytokines, chemokines, and immune 
mediators was studied in the upper respiratory tract (URT) of ferrets infected with IAV 
(H1N1 pdm09 and H3N2) and IBV. Interleukin-1, alpha interferon, and tumor necrosis 
factor alpha mRNAs levels were correlated to a peak in the viral titers. This study 
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demonstrated the similarities in the localized immune responses in ferrets when infected 
with IAV or IBV (Carolan et al., 2016). 
Experimental infection of ferrets with two B/Victoria (B/Brisbane/60/2008 and 
B/Bolivia/1526/2010) and two B/Yamagata (B/Florida/04/2006 and 
B/Wisconsin/01/2010) was done to study clinical and pathological profiles. The clinical 
illness caused by B/Brisbane/60/2008 was the most severe. B/Brisbane/60/2008 also 
caused higher viral burden compared to viruses belonging to the B/Yamagata lineage and 
established an infection in the lower respiratory tracts of the ferrets. (Huang et al., 2014).  
B/Florida/04/2006 virus was serially passaged in mice until very virulent, and then 
infected in ferrets. The mouse-adapted virus replicated in the upper and lower respiratory 
tracts of ferrets. This was the first study to show successful ferret-to-ferret transmission 
of IBV in contact and droplet conditions (E. H. Kim et al., 2015). Transmission of IBV 
between ferrets was not affected by the absence of the NB membrane protein, showing 
that the NB protein is not responsible not replication or transmission of IBV via 
respiratory droplet exposure in the in vivo ferret model (Elderfield et al., 2016).  
Some studies using ferrets were done to aid in vaccine research (Sun et al., 2019). 5-6 
months old ferrets were used to study whether the live attenuated influenza vaccine 
(LAIV), which contains IBV components, would offer cross-protection against the 
different lineages. Ferrets vaccinated with monovalent LAIV had a lower level of 
challenge virus compared to the unvaccinated ferrets (Kiseleva et al., 2018).  
3.9 Experimental IBV infections in other species  
The susceptibility of domestic pigs to Influenza B virus was demonstrated in 1966 when 
piglets that were intranasally injected with B/Budapest/10/65 demonstrated antibodies 
 48 
and infected naïve animals by contact transmission (Takatsy & Farkas, 1969). In 2015, an 
experimental challenge in pigs showed that B/Brisbane/60/2008 (Victoria lineage) and 
B/Yamagata/16/1988 (Yamagata lineage) caused symptoms and influenza-like lesions. 
B/Brisbane/60/2008 transmitted successfully to sentinel animals. 
An experimental infection involving monkeys and cats showed that these animals are 
susceptible to Influenza B virus infection by intranasal instillation, but evidence of 
contact transmission was not clearly established. The dogs included in this study were not 
susceptible to IBV infection (Paniker & Nair, 1972). SPF hamsters were infected with 
different strains of IBV to study the differences between wild type and cold adapted 
strains (Reeve, Pibermann, & Gerendas, 1981).  
Guinea pigs were infected intranasally with IBV and an adjuvant. High levels of 
hemagglutination-inhibiting antibodies and neutralizing antibodies demonstrated the 
utility of this scheme in setting up immune sera for in vitro diagnosis (Havlickova, 
Prokesova, Zanvit, Tacner, & Limberkova, 2006).  Influenza B viruses belonging to both 
B/Victoria-like and B/Yamagata-like lineages were shown to replicate in the respiratory 
tract of guinea pigs in an experiment. Injection showed and mental infection. 
Aerosol/droplet transmission was observed, with higher efficiency at 5°C compared to 
20°C (Pica, Chou, Bouvier, & Palese, 2012). Guinea pigs were vaccinated with 
neuraminidase intramuscularly and intranasally to study the ability of recombinant 
neuraminidase vaccination to prevent viral infection. The vaccinated animals were 
susceptible to infection via contact and air borne transmission routes, although the viral 
titers were lowered. Intranasal vaccination prevented virus transmission to naïve animals 
(McMahon et al., 2019). 
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Report of lack of attachment of influenza B virus to trachea and bronchi of cetaceans is 
consistent with absence of reported influenza B virus infections in these species 
(Zupancic et al., 2002).  
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Chapter 4 Replication Kinetics of IBV in Swine Primary Respiratory Epithelial 
Cells  
4.1 Abstract 
Influenza B virus (IBV) is a respiratory pathogen that poses a significant burden to 
human health. Humans are the sole reservoir of IBV, however there is evidence to show 
that swine are susceptible to IBV. In this study we infected swine primary respiratory 
epithelial cells with B/Brisbane/60/2008 (BR08), B/Florida/04/2006 (FL06), B/Hong 
Kong/286/2017 (HK17) and B/Utah/09/2014 (UT14) at 0.01 and 0.1 multiplicities of 
infection (MOI). Experiments were conducted at 33°C and 37°C, representing the 
temperatures of the upper and lower respiratory tract, respectively.  
 
4.2 Introduction 
Influenza B virus (IBV) is a respiratory pathogen belonging to the Orthomyxoviridae 
family. While IBV’s closest relative influenza A virus (IAV) predominates globally in 
terms of disease prevalence and severity, IBV also has a significant impact on the overall 
burden of influenza disease (W. P. Glezen, Schmier, Kuehn, Ryan, & Oxford, 2013). 
37% of the total healthcare costs due to influenza illness for the seasons 2001/2002 to 
2008/2009 was attributed to IBV (Yan, Weycker, & Sokolowski, 2017). 
IBV diverged into two separate lineages in the 1980s. The antigenically distinct lineages 
were named Victoria and Yamagata after B/Yamagata/16/88 and B/Victoria/2/87, which 
were the original isolates (Rota et al., 1990). While the Victoria lineage viruses only have 
one genetic clade, the B/Brisbane/60/2008 which is viewed as Group 1 of IBV, the 
Yamagata lineage viruses are divided into two clades. Group 2 in the Yamagata lineage is 
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represented by B/Brisbane/3/2007, and Group 3 is represented by 
B/Bangladesh/3333/2007. One lineage usually predominates in any given year, but 
viruses of both lineages often co-circulate during a flu season (Caini et al., 2015). 
Victoria-like viruses dominated in the late 1980s, and Yamagata lineage was predominant 
in the 1990s. The Victoria lineage re-emerged worldwide in 2001 (R. B. Chen & Holmes, 
2008). Specific nucleotide substitutions in the hemagglutinin (HA) of IBV characterize 
the specific lineage and groups within lineages (Arvia, Corcioli, Pierucci, & Azzi, 2014). 
Reassortment between and within the Victoria and Yamagata lineages can generate 
viruses having genetic variation that may affect viral antigenic properties (R. B. Chen & 
Holmes, 2008).  
Although IBV has established itself primarily as a human pathogen, there is serological 
evidence of IBV in several other mammalian species. IBVs have been isolated in dogs, 
pheasants, horses, and pigs although in several studies the criteria to establish infection 
were not met (Chang CP, 1976; Kawano J, 1978; Romvary et al., 1980; Zupancic et al., 
2000; Zupancic et al., 2002). IBV was shown to cause an infection and circulate in harbor 
seals (Phoca vitulina) and gray seals (Halichoerus grypus) (Bodewes et al., 2013).  
Serving as a natural host for influenza viruses, pigs can be infected with both avian and 
human influenza viruses. The porcine respiratory tract possesses both sialic acid α2,3-
galactose (SAα2,3-Gal) linked receptors and α2,6-galactose (SAα2,6-Gal) linked 
receptors (Ito et al., 1998). Swine, avian and human influenza viruses can undergo 
reassortment in pigs, resulting in novel influenza viruses. These novel viruses may 
contain mutations that allow transmission to humans thereby establishing a human 
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infection. They may otherwise maintain infection in pigs, making them a reservoir for 
human infection. Pigs thus play an important role in the ecology of influenza viruses. 
Antibodies to IBV in pigs have been detected in some studies, but the susceptibility of 
domestic pigs to Influenza B virus was demonstrated in 1968 when piglets that were 
intranasally injected with B/Budapest/10/65 demonstrated antibodies and infected naïve 
animals by contact transmission. Little or no clinical illness was observed (Takatsy & 
Farkas, 1969). In 2015, an experimental study was done which showed that IBV from 
both lineages can infect and replicate in pigs. IBV transmission was observed in pigs that 
were infected with viruses belonging to the Victoria lineage (Ran et al., 2015).  
Cell cultures form an important platform for vaccine production for influenza viruses. 
Factors such as the sialic acid receptors distribution and cellular environment affect the 
ability of different cell lines to replicate in influenza viruses (Rott, 1992). Continuous cell 
lines like Madin-Darby Canine Kidney (MDCK) cells have been used extensively for 
influenza studies. Insufficient antiviral defense in MDCK cells promotes efficient 
replication of IBV (Frensing et al., 2011). African green monkey kidney (Vero) cell line 
and HeLa cell lines (immortal cell line derived from cervical cancer cells) are other 
continuous cell lines that provide an alternate host system to study IBV pathogenesis and 
infection biology (Govorkova, Murti, Meignier, deTaisne, & Webster, 1996; Yamanaka, 
Shirasawa, & Yoshizawa, 1995).  
Primary cells closely resemble the in vivo characteristics of the susceptible host they are 
derived from. Exhibiting mitotic activity in the first 2-4 weeks, they have a limited 
growth capacity in vitro compared to transformed cells (Petursson & Fogh, 1963). 
Primary epithelial cells from several species have been used to gain a better 
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understanding of influenza-host interactions (Castleman & Hancock, 2014; Fischer, 
Sidhaye, King, Lane, & Pekosz, 2010; Newby, Rowe, & Pekosz, 2006; H. Y. Wang et al., 
2018; Zeng et al., 2019; Zeng et al., 2013; Zhao, Liang, & Ji, 2011). Moreover, primary 
epithelial cells of swine origin are used to study the infection models of various diseases 
including influenza (Allen C Bateman et al., 2010; Guseva, Knight, Whittimore, & 
Wyrick, 2003; Kasza, Bohl, & Jones, 1960; Schierack et al., 2006).  
Mink lung epithelial cells actively supported the replication of IBV to titers comparable 
to MDCK cells (Schultz-Cherry et al., 1998). Chick embryo brain cultures too supported 
the replication of influenza B viruses when enriched with neurons or astroglial cells 
(Parker et al., 1997). It was also seen that ferret tracheal epithelial cells when infected 
with IBV showed productive replication (Elderfield et al., 2015). Our lab previously 
demonstrated that swine primary respiratory epithelial cells derived from a day-old 
gnotobiotic piglet could be infected with four types of influenza viruses (Sreenivasan et 
al., 2019). 
This study looked the replication kinetics of IBV in swine primary respiratory epithelial 
cells derived from the nasal turbinate, trachea and lung cells of a day-old gnotobiotic 
piglet at different multiplicities of infection of the virus. The primary cells were infected 
with IBV strains belonging to both Victoria and Yamagata lineages. Temperature 
dependent replication of IBV was seen at both 33°C and 37°C. B/Hong Kong/286/2017 
(Victoria lineage) grew to the highest titers in nasal turbinate and lung primary epithelial 
cells.  
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4.2 Materials and Methods 
Swine primary nasal turbinate, trachea and lung cells were isolated from a day old 
gnotobiotic piglet. These cell types were developed and characterized as described by 
Sreenivasan et. all (Sreenivasan et al., 2019). The primary cells were grown in 
Dulbecco’s Modified Eagle Medium (DMEM/F-12), 10% FBS (PAA Laboratories Inc., 
Dartmouth, MA, USA) and penicillin-streptomycin (100 U/mL) (Life Technologies, 
Carlsbad, CA, USA), Mouse epidermal growth factor (EGF) (Sigma (5 ng/mL)), insulin 
(5 µg/mL) transferrin (5 µg/mL) and selenium (5 ng/mL) (Sigma). All cell cultures were 
maintained in a humidified incubator at 37°C or 33°C with 5% CO2. The primary cells of 
passages 2 to 10 were used for this study.  
4.2.1 Culture of Influenza B viruses 
The Influenza B viruses used in this study were B/Brisbane/60/2008 (BR08), 
B/Florida/04/2006 (FL06), B/Hong Kong/286/2017 (HK17) and B/Utah/09/2014 (UT14). 
For this study, MDCK cells were maintained in Dulbecco’s Modified Eagle medium, 
supplemented with 10% fetal bovine serum (FBS) (PAA Laboratories Inc., Dartmouth, 
MA, USA) and penicillin-streptomycin (Life Technologies, Carlsbad, CA, USA) (100 
U/mL). MDCK cells were cultured in the T-25 flask, inoculated with the virus inoculum 
at 0.01 multiplicity of infection (MOI) and incubated at 37°C in 5% CO2 for 1 h. After 
infection, the virus growth medium, containing fresh DMEM with 0.3% bovine serum 
albumin (BSA) made from 6% stock, 1 μg/mL tolylsulfonyl phenylalanyl chloromethyl 
ketone (TPCK)-treated trypsin (Sigma, Saint Louis, MO, USA) and penicillin-
streptomycin (100 U/mL) (Life Technologies, Carlsbad, CA, USA), was added for 
further incubation at 37°C in 5% CO2 for 72 h. The infected cell cultures were freeze-
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thawed. For removal of cellular debris, the supernatant was spun at 500× g for 10 min at 
4°C. The viruses were stored at -80°C until further use. The Reed and Muench method 
was applied to determine the virus titers (50% cell culture infectious dose (TCID50) 
endpoint dilution assay) in MDCK cells (Reed & Muench, 1938a). 
4.2.2 Replication Kinetics 
Approximately 2 × 105 cells/well were seeded on 24 well plates. The cells were 
respectively infected with B/Brisbane/60/2008 (BR08) or B/Florida/04/06 (FL06) or 
B/Hong Kong/286/2017 (HK17) or B/Utah/09/2014 (UT14). Virus growth medium for 
primary cells included Opti-MEM (Thermofisher Scientific, Waltham, MA), 0.001% 
(0.01 µg/ml) TPCK Trypsin (Pierce, Thermofisher Scientific, Waltham, MA), and 1% 
antibiotic-antimycotic (Thermofisher Scientific, Waltham, MA). MDCK cells were 
infected at the same MOI, with DMEM, 0.1% (1 µg/ml) TPCK Trypsin (Pierce, 
Thermofisher Scientific, Waltham, MA), and 1% antibiotic-antimycotic (Thermofisher 
Scientific, Waltham, MA). Samples were collected at 24 h intervals until 120 h post 
infection. 
Approximately, 1 × 104 MDCK cells were seeded on flat bottom 96 well plate (Greiner 
bio-one, NC, USA) and incubated overnight. Serial ten-fold dilutions of the samples were 
prepared in virus infection media and were inoculated on pre-seeded MDCK 96-well cell 
culture plates. The inoculated plates were incubated for 5 days at respective temperatures. 
The infectivity of the virus was determined by hemagglutination assay using 1% Turkey 
red blood cells (Lampire Biological Laboratories, Pipersville, PA, USA). Titers were then 
calculated using Reed and Muench formula (REED & MUENCH, 1938b). 
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4.3 Results 
              
 
              
Figure 4.1 Morphology of porcine primary respiratory epithelial cells. Panel (a) shows 
uninfected nasal turbinate, trachea and lung primary cells under a phase contrast 
microscope (20x). Panel (b) shows nasal turbinate, trachea and lung primary cells 
infected with B/Hong Kong/286/2017 (72h post-infection) under a phase contrast 
microscope (10x). 
 
 
a 
b 
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Figure 4.2 Swine primary nasal turbinate epithelial cells were infected with (a) 0.01 MOI 
or (b) 0.1 MOI of B/Brisbane/60/2008 (BR08) or B/Florida/04/2006 (FL06) or B/Hong 
Kong/286/2017 (HK17) or B/Utah/09/2014 (UT14) at 33°C and 37°C. Virus titers were 
expressed in log10TCID50/ml. Dotted line represents the replication kinetics at 33°C. 
Data shown here are representative of two independent experiments performed in 
triplicates ± SE. 
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Figure 4.3 Swine primary trachea epithelial cells were infected with (a) 0.01 MOI or (b) 
0.1 MOI of B/Brisbane/60/2008 (BR08) or B/Florida/04/2006 (FL06) or B/Hong 
Kong/286/2017 (HK17) or B/Utah/09/2014 (UT14) at 33°C and 37°C. Virus titers were 
expressed in log10TCID50/ml. Dotted line represents the replication kinetics at 37°C, 
while the bold line represents the kinetics at 33°C. Data shown here are representative of 
two independent experiments performed in triplicates ± SE. 
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Figure 4.4 Swine primary lung epithelial cells were infected with (a) 0.01 MOI or (b) 0.1 
MOI of B/Brisbane/60/2008 (BR08) or B/Florida/04/2006 (FL06) or B/Hong 
Kong/286/2017 (HK17) or B/Utah/09/2014 (UT14) at 33°C and 37°C. Virus titers were 
expressed in log10TCID50/ml. Dotted line represents the replication kinetics at 37°C, 
while the bold line represents the kinetics at 33°C. Data shown here are representative of 
two independent experiments performed in triplicates ± SE 
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Figure 4.5 MDCK cells were infected with (a) 0.01 MOI or (b) 0.1 MOI of 
B/Brisbane/60/2008 (BR08) or B/Florida/04/2006 (FL06) or B/Hong Kong/286/2017 
(HK17) or B/Utah/09/2014 (UT14) at 33°C and 37°C. Virus titers were expressed in 
log10TCID50/ml. Dotted line represents the replication kinetics at 37°C, while the bold 
line represents the kinetics at 33°C. Data shown here are representative of two 
independent experiments performed in triplicates ± SE 
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Virus Max. Titer Log10TCID50/ml (33˚C )  
BR08 MDCK (5.36) > Trachea (3.43) > NT (3.35) > Lung (2.43) 
FL06 MDCK (3.94) > Trachea (3.45) > NT (3.37) > Lung (2.9) 
HK17 MDCK (4.51) > NT & Trachea (4.36) > Lung (4.33) 
UT14 Trachea (4.39) > MDCK (4.34) > Lung (3.4) > NT (3.29) 
 
Virus Max. Titer Log10TCID50/ml (33˚C )  
BR08 MDCK (5.36) > Trachea (3.43) > NT (3.35) > Lung (2.43) 
FL06 MDCK (3.94) > Trachea (3.45) > NT (3.37) > Lung (2.9) 
HK17 MDCK (4.51) > NT & Trachea (4.36) > Lung (4.33) 
UT14 Trachea (4.39) > MDCK (4.34) > Lung (3.4) > NT (3.29) 
 
Table 4.1 shows the peak viral titers (log10TCID50/ml) B/Brisbane/60/2008, 
B/Florida/04/06, B/Hong Kong/286/2017 and B/Utah/09/2014 grew to in nasal turbinate, 
trachea, lung and MDCK cells  in decreasing order of titers at 33˚C and 37˚C at 0.01 
multiplicity of infection. 
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Virus Peak Titer Log10TCID50/ml (33˚C)  
BR08 MDCK (5.35) > Lung (4.46) > Trachea (4.14) > NT (3.84) 
FL06 MDCK (5.57) > Trachea (5.38) > NT & Lung (4.25) 
HK17 Lung (4.47) > MDCK (4.45) > NT (4.31) > Trachea (3.42) 
UT14 MDCK (5.40) > Trachea and Lung (4.34) > NT (3.99) 
 
Virus Peak Titer Log10TCID50/ml (37˚C)  
BR08 MDCK (4.61) > Trachea (3.16) > NT (3.04) > Lung (2.85) 
FL06 MDCK (5.24) > NT (3.7) > Trachea (3.6) > Lung (3.46)  
HK17 NT (4.65) > Lung (4.49) > MDCK (4.45) > Trachea (3.3) 
UT14 MDCK (5.44) > NT (4.3) > Trachea (3.38) > Lung (3.35) 
 
Table 4.2 shows the peak viral titers (log10TCID50/ml) B/Brisbane/60/2008 (BR08), 
B/Florida/04/06 (FL06), B/Hong Kong/286/2017 (HK17) and B/Utah/09/2014 (UT14) 
grew to in nasal turbinate(NT), trachea (T), lung (L) and MDCK cells  in decreasing 
order of titers at 33˚C and 37˚C at 0.1 multiplicity of infection. 
 
   
Temperature & MOI NT Trachea Lung MDCK 
33˚C and 0.01 MOI HK17 (4.36) UT14 (4.49) HK17 (4.33) BR08 (5.36) 
33˚C and 0.1 MOI HK17 (4.31) FL06 (5.38) HK17 (4.47) FL06 (5.57) 
37˚C and 0.01 MOI HK17 (3.58) FL06 (3.53) HK17 (3.51) BR08 (5.32) 
37˚C and 0.1 MOI HK17 (4.65) FL06 (3.66) HK17 (4.49) UT14 (5.44) 
 
Table 4.3 shows the peak titers B/Brisbane/60/2008 (BR08), B/Florida/04/06 (FL06), 
B/Hong Kong/286/2017 (HK17) and B/Utah/09/2014 (UT14) replicated to in swine 
primary nasal turbinate (NT), trachea (T), lung (L) and MDCK cells at different 
temperatures and MOIs 
 
 
Swine primary respiratory epithelial cells derived from nasal turbinate, trachea and lungs 
were infected with four IBV strains (Figure 4.1). The viruses belonging to the Victoria 
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lineage were B/Brisbane/60/2008 (BR08) and B/Hong Kong/286/2017 (HK17); 
Yamagata lineage were B/Florida/04/2006 (FL06) and B/Utah/09/2014 (UT14). 
Replication kinetics in the primary cells were compared to MDCK cells. The TCID50 
titers of the stock viruses were 3.16x106 TCID50/ml and 2.67x10
6 TCID50/ml for BR08, 
2.37x106 TCID50/ml for FL04; 1.58x10
6 TCID50/ml and 1.9x10
6 TCID50/ml for HK17; 
3x107 TCID50/ml for UT14. 
Infection experiments were done at 0.01 MOI and 0.1 MOI. TPCK trypsin was used at a 
concentration of 0.01 µg/ml (0.001%) on the primary epithelial cells to cause minimum 
cell toxicity, whereas 1µg/ml (0.1%) was used for infecting MDCK cells.  
4.3.1 Replication Kinetics in Nasal Turbinate Cells at 0.01 MOI 
All four viruses replicated productively in nasal turbinate cells at 33˚C (Figure 4.2a). 
FL06 reached a peak of 3.37 logs by 48 hours post infection (hpi), whereas BR08, HK17 
and UT14 reached their maximum titers of 3.35 logs, 4.36 logs and 3.29 logs by 72 hpi. 
All four viruses followed a similar trend to MDCK cells at 33˚C; reaching their peak 
titers at the same time points in nasal turbinate cells as in MDCK cells.  
Replication of the four IBVs at 37˚C was less productive than the replication at 33˚C. 
While HK17 grew best to a titer of 3.58 logs, FL06 and UT14 grew to titers 2.56 logs and 
2.44 logs respectively. Interestingly, BR08 had a low titer of 1.77 logs by 72 hpi at 37˚C. 
MDCK cells supported all the viruses better than nasal turbinate cells at 37˚C.  
4.3.2 Replication Kinetics in Nasal Turbinate Cells at 0.1 MOI 
By 24h post infection, BR08 replicated to a titer of 3.84 logs at 33˚C and 3.04 logs at 
37˚C, showing no significant difference in titers between the two temperatures. Similarly, 
HK17 grew to titers of 4.31 logs at 33˚C and 4.65 logs at 37˚C by 72 hpi while UT14 
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grew to 3.99 logs at 33˚C and 4.34 logs at 37˚C. Contrastingly, FL06 grew better at 33˚C, 
reaching a peak titer of 4.25 logs at 33˚C (Figure 4.2b).  
4.3.3 Replication Kinetics in Trachea Cells at 0.01 MOI 
Trachea cells supported the replication of the four IBVs when infected at 33˚C (Figure 
4.3a). At this temperature, BR08 and HK17 had no titer by 24 hpi, whereas FL06 and 
UT14 began replicating by 24 hours post-infection. BR08, HK17 and UT14 showed 
higher peak viral titers at 33˚C when compared to 37˚C. The titers obtained were 3.43 
logs for BR08, 4.36 logs for HK17 and 4.49 logs for UT14. FL06 replicated equally well 
at both temperatures reaching 3.53 logs at 37˚C. Interestingly, all the viruses had no titer 
by 120 hpi in the trachea cells.  
4.3.4 Replication Kinetics in Trachea Cells at 0.1 MOI 
FL06 replicated the best in trachea cells reaching a titer of 5.38 logs by 48 hours post-
infection. BR08 and UT14 followed similar patterns of replication, reaching peak titers of 
4.14 logs and 4.34 logs respectively by 72 hpi. HK17 exhibited the lowest titers at 33˚C, 
reaching 3.42 logs by 96 hpi. While HK17 grew equally well at 33˚C and 37˚C, BR08, 
FL06 and UT14 were supported better by trachea cells at 33˚C. The pattern of replication 
varied as well, with BR08, FL06 and HK17 reaching peak titers earlier at 37˚C. By 120 
hpi, BR08 and FL06 were not replicating (Figure 4.3b). 
 
4.3.5 Replication Kinetics in Lung Cells at 0.01 MOI 
Lung cells support the replication of all four viruses, with HK17 growing most efficiently 
to a peak titer of 4.33 logs at 72 hpi (Figure 4.4a). BR08 and UT14 replicated to higher 
titers at 33˚C, reaching peak titers of 2.43 logs at 48 hpi and 3.40 logs at 48 hpi 
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respectively. FL06 replicated more efficiently at 37˚C with a peak titer of 3.38 logs by 24 
hpi. This was similar to the pattern of replication in MDCK cells at 0.01 MOI, where 
FL06 grew better at 37˚C, reaching a peak titer of 4.36 logs. By 120 hpi only FL06 had a 
titer. 
4.3.6 Replication Kinetics in Lung Cells at 0.1 MOI 
BR08, FL06 and UT14 reached peak titers of 4.46 logs at 48 hpi, 4.25 logs at 72 hpi and 
4.34 logs at 48 hpi respectively in the 33˚C experiment (Figure 4.4b). These three viruses 
replicated less efficiently in at 37˚C, reaching peak titers of 2.85 logs at 72 hpi (BR08), 
3.46 logs at 24 hpi (FL06) and 3.35 logs at 48 hpi (UT14). HK17 displayed similar 
growth curves and peak viral titers growing of 4.45 logs at 48 hpi at both temperatures.  
4.3.7 Replication Kinetics of MDCK Cells at 0.01 MOI 
All four viruses reached high titers in MDCK cells at 33˚C and 37˚C (Figure 4.5a). No 
significant differences in titers were seen between the two temperatures for BR08, HK17, 
and UT14. BR08 grew the best at 33˚C, reaching 5.36 logs, whereas HK17 and UT14 
grew to peak titers of 4.51 logs and 4.34 logs respectively. BR08 grew to a high titer of 
5.32 logs by 72 hpi at 37˚C, while HK17 and UT14 replicated to titers of 4.42 logs at 48 
hpi and 4.40 logs at 72 hpi respectively. FL06 replicated slightly better at 37˚C reaching a 
titer of 4.36 logs by 48 hpi, whereas it only grew to 3.94 logs at 48 hpi in the 33˚C 
experiment. 
 
4.3.8 Replication Kinetics of MDCK Cell at 0.1 MOI 
When MDCK cells were infected with one of the four viruses at 0.1 MOI, the titers 
obtained at 37˚C were lesser than or equal to the titers obtained at 33˚C. BR08 showed a 
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significant difference in titers between the two temperatures, growing to 5.35 logs by 48 
hpi at 33˚C, whereas at 37˚C it grew to a peak titer of 4.61 logs by 48 hpi. At 33˚C FL06, 
HK17 and UT14 grew to titers of 5.57 logs at 48 hpi, 4.45 logs at 48 hpi and 5.40 logs at 
48 hpi respectively. Similar peak titers of 5.24 logs at 24 hpi, 4.45 logs at 48 hpi and 5.44 
logs at 48 hpi were seen for these three viruses at 37˚C (Figure 4.5b).  
BR08 showed productive replication at 33˚C in all three primary cells and MDCK cells. 
In the 33˚C experiments, the highest titers were seen in MDCK cells (5.3 logs) followed 
by lung cells (4.46 logs). Higher titers were observed when all cells were infected with 
BR08 at 0.1 MOI compared to 0.01 MOI (Table 4.1 and 4.2). In the 37˚C experiments, 
replication of BR08 was restricted to less than 2 logs in the primary cells at 0.01 MOI. 
Interestingly, MDCK cells yielded a titer of 5.3 logs when infected with BR08 at 37˚C 
and 0.01 MOI. 
FL06 showed the highest titer of 5.57 logs in MDCK cells when infected at 33˚C and 0.1 
MOI. Unlike BR08, in the 0.01 MOI experiments, comparable titers were seen at both 
temperatures. Amongst the primary cells, the highest titer was observed in trachea cells 
(5.38 logs) at 33˚C and 0.1 MOI. It was seen that in the 33˚C experiments, peak titers of 
FL06 were reached at 48h in all cell types except lung cells at 0.1 MOI which showed the 
peak titer at 72h. 
HK17 showed productive replication at both temperatures and MOIs. No significant 
differences were seen in titers between 33˚C and 37˚C in the 0.1 MOI experiment, 
whereas at 0.01 MOI, the titers at 33˚C were a log higher than titers at 37˚C in the 
primary cells. The highest titer for HK17 (4.65 logs) was seen in nasal turbinate cells at 
37˚C in the 0.1 MOI experiment (Table 4.3).  
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UT14 grew best in MDCK cells at 0.1 MOI and 37˚C, reaching a peak titer of 5.44 logs 
by 48 hpi. At 0.01 MOI, nasal turbinate and trachea cells exhibited a higher titer at 33˚C 
compared to 37˚C. No significant differences in titers were seen in lung and MDCK cells 
between both temperatures. At 0.1 MOI, UT14 grew best in MDCK cells reaching a peak 
titer of 5.44 logs, followed by nasal turbinate cells in which it replicated to 4.34 logs at 72 
hpi. 
 
4.4 Discussion 
This study looked at the utility of a swine isogenous cell culture system in studying the 
replication kinetics of influenza B virus (IBV) at ambient temperatures that correspond to 
the upper and lower respiratory tract of swine. The nasal turbinate trachea and lung swine 
primary respiratory epithelial cells represent the upper, middle and lower respiratory tract 
of swine, respectively. The replication of B/Brisbane/60/2008 (BR08) and B/Hong 
Kong/286/2017 (HK17) belonging to the Victoria lineage, and B/Florida/04/06 (FL06) 
and B/Utah/09/2014 (UT14) belonging to the Yamagata lineage was studied at 33˚C and 
37˚C. The three primary cells, and MDCK cells which were used as a positive control, 
were infected with the four strains of IBV at 0.01 and 0.1 multiplicities of infection. 
Though humans are accepted to be the only reservoir for IBV, there is evidence of IBV 
infections in non-human species. Antibodies to IBV detected in swine in the 1960s and in 
2015 indicate the exposure of swine to this virus (Ran et al., 2015; Takatsy & Farkas, 
1969). Furthermore, animal studies conducted have shown that IBV is capable of 
replicating in swine (Takatsy & Farkas, 1969). The natural infection of IBV in pigs in 
Taiwan, although sporadic, is a public health concern as it can lead to human-swine-
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human transmission in the future (Tsai & Tsai, 2019). Reassortment of IBV with other 
influenza viruses in pigs can also create the potential for new zoonotic viruses.  
This study demonstrates that IBV is capable of replicating in the in vitro model of the 
swine respiratory tract. Our previous study showed that BR08 and FL06 replicated in the 
nasal turbinate, trachea and lung primary epithelial cells when infected with 0.1 MOI at 
33˚C and 37˚C (Sreenivasan et al., 2019). Here we show that appreciable viral titers can 
be observed at a lower multiplicity of infection (0.01 MOI) as well. In addition, 
successful replication of contemporary strains HK17 and UT14 is observed in these 
primary cells.  
IBV replicated in a temperature dependent manner in all three primary cells. Peak titers at 
33˚C were greater than or equal to titers at 37˚C for most of the experiments. Exceptions 
include HK17 which when infected at 0.1 MOI in the nasal turbinate cells grew to 0.3 
logs higher at 37˚C. Infection of MDCK cells did not result in significant differences in 
titer between the two temperatures.  
The growth of BR08, FL06 and UT17 was supported best by MDCK cells, which lack 
the anti-influenza activity of canine Mx protein (Frensing et al., 2011). Interestingly, 
HK17 (Victoria lineage) grew to the highest titers in nasal turbinate and lung cells. This 
is in line with the swine seroprevalence study done in 2015, which showed that higher HI 
antibody titers were seen in viruses belonging to the Victoria lineage when compared to 
the Yamagata lineage (Ran et al., 2015). The growth of BR08, FL06 and UT14 was sub-
optimal in the primary cells, although close to that in MDCK cells at certain conditions. 
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Notably, lineage-specific differences in replication could not be observed in this study. 
Further investigation into the molecular basis for the differences in replication between 
the older BR08 and contemporary HK17 will shed more light on the role of swine in the 
pathogenesis of IBV.  
The submerged monolayer of swine primary cells used in this study does not accurately 
mimic the three-dimensional architecture of the swine respiratory tract. Experiments 
performed in 3D cell culture systems or air liquid interface systems would provide 
additional information at a cellular level when studying the tropism and infectivity of 
influenza viruses (Allen C. Bateman, Karasin, & Olsen, 2013; Elderfield et al., 2015; H. 
Y. Wang et al., 2018).  
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